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ABSTRACT
Inspired by the Sandcastle Worm, biomimetic of the water-borne adhesive was 
developed by complex coacervation of the synthetic copolyelectrolytes, mimicking the 
chemistries of the worm glue. The developed underwater adhesive was designed for 
sealing fetal membranes after fetoscopic surgery in twin-to-twin transfusion syndrome 
(TTTS) and sealing neural tissue of a fetus in aminiotic sac for spina bifida condition.
Complex coacervate with increased bond strength was created by entrapping 
polyethylene glycol diacrylate (PEG-dA) monomer within the cross-linked coacervate 
network. Maximum shear bond strength of ~ 1.2 MPa on aluminum substrates was 
reached. The monomer-filled coacervate had complex flow behavior, thickening at low 
shear rates and then thinning suddenly with a 16-fold drop in viscosity at shear rates near
6 s-1. The microscale structure of the complex coacervates resembled a three-dimensional 
porous network of interconnected tubules. This complex coacervate adhesive was used in 
vitro studies to mimic the uterine wall-fetal membrane interface using a water column 
with one end and sealed with human fetal membranes and poultry breast, and a defect 
was created with an 11 French trocar. The coacervate adhesive in conjunction with the 
multiphase adhesive was used to seal the defect. The sealant withstood an additional 
traction of 12 g for 30-60 minutes and turbulence of the water column without leakage of 
fluid or slippage. The adhesive is nontoxic when in direct contact with human fetal 
membranes in an organ culture setting.
A stable complex coacervate adhesive for long-term use in TTTS and spina bifida 
application was developed by methacrylating the copolyelectrolytes. The methacrylated 
coacervate was crosslinked chemically for TTTS and by photopolymerization for spina 
bifida. Tunable mechanical properties of the adhesive were achieved by varying the 
methacrylation of the polymers. Varying the amine to phosphate (A/P) ratio in the 
coacervate formation generated a range of viscosities. The chemically cured complex 
coacervate, with sodium (meta) periodate crosslinker, was tested in pig animal studies, 
showing promising results. The adhesive adhered to the fetal membrane tissue, with 
maximum strength of 473 ± 82 KPa on aluminum substrates. The elastic modulus 
increased with increasing methacrylation on both the polyphosphate and polyamine 
within the coacervate. Photopolymerized complex coacervate adhesive was photocured 
using Eosin-Y and treiethanolamine photoinitiators, using a green laser diode. Soft 
substrate bond strength increased with increasing PEG-dA concentration to a maximum 
of ~90 kPa. The crosslinked complex coacervate adhesives with PEG networks swelled 
less than 5% over 30 days in physiological conditions. The sterile glue was nontoxic, 
deliverable through a fine cannula, and stable over a long time period. Preliminary animal 
studies show a novel innovative method to seal fetal membrane defects in humans, in 
utero.
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This chapter is an introduction to complex coacervate adhesives, inspired by the 
sandcastle worm, for the repair of fetal defects. The inspiration behind this work, the 
Sandcastle Worm, is thoroughly covered. The concepts that are key to this thesis are 
covered by explaining the complex coacervation. The formation of the synthetic 
underwater adhesive complex coacervate is discussed. The motivation behind this work 
comes from lack of adhesives to seal soft tissues, specifically for sealing defects in 
environments where adhesives have to be applied under aqueous conditions, like in utero. 
Research for this thesis is based on developing a synthetic complex coacervate adhesive 
for sealing fetal defects for two applications: Twin-Twin transfusion Syndrome and Spina 
Bifida, which represents a model for other fetal defect repair. An outline of this thesis is 
given at the end of this chapter.
1.1 Adhesives
Adhesives can be defined as materials that can join two surfaces together upon 
application and resist its separation [1]. Many terms like glue, cement, paste, etc., can be 
used interchangeably to define adhesives. Adhesion is a property often used to signify 
attraction between surfaces or particles. Adhesion forces itself to operate across the 
interface due to molecular van der Waals forces, dipole-dipole interactions, hydrogen
bonding, or covalent bonding [2]. The materials joined by the adhesive are known as 
substrates.
Adhesives have been around for centuries to glue materials together. One of the 
first adhesives dates back 200,000 years ago, using birch-bark-tar glue to fasten spear 
stone flake to a wooden shaft in Italy [3]. It is not until the last century, however, that the 
advances in adhesion and adhesives have been made. A major component playing a key 
role in these advances is the material developments of synthetic polymers in the 20th 
century. These materials have balance properties that allow them to adhere to other 
materials and transmit loads or forces between the two substrates [1]. Increasing demands 
in applications has spurred the research and development of specific adhesive 
formulations.
1.1.1 Soft Tissue Adhesives
An advance in adhesive technologies in all fields and applications has led to its 
use in medicine. Sutures and mechanical fixations were primarily used to bind tissue and 
bone together and still continue to be used in many areas today. Although a lot of 
progress has been made over the past decade in medicine, a suture is still the 
conventional method to close skin incisions. Alternative methods for soft tissue repair 
over the years have led to the development of soft tissue adhesives. Adhesives for tissue 
repair can replace sutures in many cases as well as limit their use. Gluing has many 
advantages because its fast and uncomplicated technique causes very little damage to the 
surrounding tissue [4]. A homogenous load is distributed between the bonding tissues. 
They are especially useful in applications where suturing is difficult, whether by location 
or the type of tissue that is being repaired. Using an adhesive also helps in sealing the
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3wound to prevent any leakage of fluid.
1.1.2 Underwater Adhesives
Since our body is mostly made up of water, maintaining adhesion underwater is a 
major challenge. A soft tissue adhesive must be able to bind the tissue together with 
adequate strength, be nontoxic, and maintain its integrity until wound healing occurs. 
Getting adequate strength for biological environments is a difficult task to accomplish for 
many bioadhesives. Synthetic adhesives used today are normally designed for dry 
applications and perform poorly in the presence of water [5]. They can have high strength 
to start out with but will eventually fail due to poor interfacial adhesion in watery 
environments [6-8]. Therefore, a good underwater adhesive must have robust interfacial 
adhesion to wet surfaces, without any surface preparation, while depositing the adhesive 
under water, with controlled solidification [5]. A suitable soft tissue adhesive must be 
able to overcome binding tissue surfaces in wet environments, maintain their strength 
over time, and be nontoxic.
1.2 Sandcastle W orm Inspired
We can learn a lot from Nature. We are inspired by our surroundings and adapt 
from them. There are many solutions we can derive to our modern day problems by 
observing natural phenomena. From a material scientist’s perspective, a wide variety of 
materials with different functions serve as a source of inspiration [9]. Taking these 
materials from observation to in-depth analysis leads to bioinspired materials.
To tackle the underwater adhesion problem, marine organisms (like mussels, 
barnacles, and sandcastle worms) are being studied. These organisms secrete a liquid
protein adhesive, which adheres to all types of wet surfaces, whether organic or inorganic 
[10]. Intrigued by these natural organisms, scientists have developed biomimetic 
underwater adhesives for strong adhesion to biological tissue [11-13]
The sandcastle worm (Phragmatopoma Californica, P-Cal) is important to our 
research. This organism is unique in that it is able to bind dissimilar materials together 
under seawater in a single step without much surface preparation, with a self-contained 
mechanism to trigger a setting reaction, building a protective shell that it lives in [14]. 
The adhesive is secreted as a colloidal suspension with very low interfacial tension, 
which allows it to spread easily over the substrate while remaining very cohesive and not 
dispersing into the ocean [13]. Despite all the turbulent forces, temperature changes, and 
fluctuating salinities taking place in the ocean, the tubular structure that the worm builds 
does not fall apart [15]. The sandcastle worm cement represents the simplest permanent 
bioadhesive investigated to date [16]. Compared to mussels and barnacles, which directly 
attach themselves to the substrates, the sandcastle worm is mobile within the tube that it 
builds. Over the years these organisms have evolved workable materials solutions. By 
gaining knowledge and understanding of these natural phenomena, we are able to design 
and synthesize adhesives in wet environments [17]. Based on the basic chemistry of the 
natural worm glue, our synthetic complex coacervate adhesive is made.
1.2.1 Sandcastle Worm (Phragmatopoma Californica)
Phragmatopoma Californica (P. californica) is a marine polychaete that belongs 
to the family of sabellariids. P. californica (also called the sandcastle worm) lives along 
the coast of California. The sabellariids (known as tube-dwelling polychaetes) build 
massive reef-like mounds, consisting of tubes held together in honeycomb like
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arrangements (Figure 1.1A and 1.1B). These tubular homes that the worm lives in almost 
resemble large-stone masonry [18].
Sabellariids are different than other shell-dwelling marines, such that that they 
gather mineral phases from the ocean and secrete a proteinaceous glue to bind the sand 
particles together [20], rather than making a complete mineralized shell [21]. The 
sandcastle worm has ciliated tentacles (Figure 1.1 C) that capture and transport food and 
particles from the ocean to its mouth [22]. They collect passing materials like sand grains, 
calcareous shells, or debris from water to bind. The food is ingested through the mouth, 
and the particles are evaluated for the right size, shape, composition, and surface 
chemistry at the building organ near the mouth. The unsuitable particles are cast away, 
and the suitable particles are pressed onto the existing tube in the best position to 
minimize any gaps in the structure [19]. Particles at the point of contact are spotted with 
glue and pressed into place. The worm wriggles the particle until the glue sets, taking 
approximately 20-30 sec [23]. Each worm builds the tube that it lives in for physical 
protection. A large colony of reef like structures is built by a coordinated effort, which 
affects the reef ecology [24]. The exact strength of these tubular structures is difficult to 
assess, but their location in these turbulent environments and the durability of the 
structure suggest a robust construction [13].
1.2.2 Sandcastle Worm Adhesive Structure
The sandcastle worm sets into a flexible leathery material with a structure of 
solidified foam, as shown in Figure 1.2 [20]. In the laboratory, the worm is given glass 
beads, which it uses to build a glass bead tube (Figure 1.2A). Its structure was analyzed 
using laser scanning confocal and atomic force microscopies. A porosity gradient was
5
6(A) Photo courtesy of Dr. Jerome Fournier.
Figure 1.1 Reef-building sabellariid tubeworms. A) Lateral growth of isolated dome­
shaped colonies of S. alveolota (foreground) leads to fusion of colonies into a continuous 
tabular surface covering the beach. B) Closer view of a colony of P. californica. Each 
tube contains an individual worm. C) Left: P. californica removed from tubular shell. 
White bracket indicates parathorax region that contains the adhesive gland. Right: 
Zirconium oxide beads have been glued onto the anterior end of the natural tube. Arrow 
indicates the operculum [19], Reprinted with permission from C. S. Wang, and R. J. 
Stewart, “Multipart Copolyelectrolyte Adhesive of the Sandcastle Worm, 
Phragmatopoma Californica (Fewkes): Catechol Oxidase Catalyzed Curing Through 
Peptidyl-DOPA,” Biomac., 14 [5] 1607-1617 (2013). Copyright 2013 American 
Chemical Society.
7Figure 1.2 SEM of sandcastle adhesive. A) A tube of partially rebuilt with glass beads. 
The glue was applied only at four contact points (arrows); B) Sandcastle worms placed 
on coverslips glue glass beads to the surface. The glue fractured when the bead was pried 
away; C) The foamy interior in the right box in B; D) A spot of glue left on a glass bead, 
indicating liquid until set; E) Threads and nonporous skin layer on glue; F) Foamy 
interior imaged with backscattered electron detector. Distinct layers on the surface 
(arrow) and linking the pores are visible. Scale bar in (B and D) 50 ^m; (C and E) 15 ^m; 
F) 5 [26], Springer, New York, and Biological Adhesive Systems, Editors J. V. 
Byem, I. Grunwalds, 2010, Morphology of the Adhesive System in the Sandcastle 
Worm, Phragmatopoma Californica, S. Wang, K. K. Svendsen, and R. J. Stewart, is 
given to the publication in which the material was originally published, by adding; with 
kind permission from Springer Science and Buisness Media.
observed with hardly any porosity on both the outside of the glue and the solid foam 
within the internal structure (Figure 1.2 B, C, D, E, & F). Showing 50% porosity down 
the center of the adhesive joint [23]. This was similar to the structure of the byssall 
adhesive plaques of the mussels. The foamy structure of the adhesive is very 
advantageous because it increases the adhesives elasticity and toughness (amount of 
energy that a material can absorb before failing) [25]. A foam packing material is more 
flexible and absorbs the dissipated energy, which decreases the amount of damage in the 
tube. The porous material saves the amount of adhesive used to glue the particles. The 
foam also serves as a cushion between the mismatched modulus of the rigid particles, 
linking the flexible cement that is key for binding various substrates [17]. These key 
properties play a big role in strengthening the joint by absorbing and dissipating strain 
energies. This gives the water-borne adhesive of the sandcastle worm a multiscale energy 
absorbing system that helps the worm deal with the turbulent environment of the ocean.
1.2.3 Sandcastle Worm Adhesive Composition
The composition of P. californica adhesive is known to be a proteinaceous, 
enriched with amino acids consisting of serine, glycine, lysine, and large amounts of 2,4- 
dihydroxyphenyl-L-alanine (DOPA) [18, 20, 27]. It is very similar in composition to the 
byssal adhesive of mussels [28-29], but much less complex. An amino acid and 
elemental analysis of the adhesive resulted in a mixture of three highly polar proteins 
Pc1, Pc2, and Pc3 with significant amounts of Ca2+ and Mg2+ [16, 18, 20]. Pc1 and Pc2 
are positively charged proteins that are basic with pI > 9. The Pc1 protein consists of 
three residues, glycine (45 mol%), lysine (14 mol%), and tyrosine (19 mol%), and is 
highly repetitive and simple. The Pc2 is mostly histidine rich with lysine. Pc3 protein
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exists in two variants (A, B) containing 4-13 serine residues with a single tyrosine 
residue. Because 95% of the serines in Pc3 are being phosphorylated, it is highly acidic, 
pI 0.5-1.5 [20]. This results in positively and negatively charged amino acids, with 30% 
phosphate sidechains and 10-20% amine sidechains in the worm’s glue, as shown in 
Figure 1.3. Magnesium and calcium were other major components in the glue, with 4-5 
times Mg to Ca and total cations to phosphate being a 1500 ppm ratio.
1.2.4 Sandcastle Worm Adhesive Curing
Many mechanisms come to play to solidify the worm glue. The glue initially sets 
in 30 sec followed by a covalent crosslinking that takes up to hours. First the initial set of 
the glue seems to be triggered by a pH change, from pH <6 inside the sandcastle worm, 
to pH > 8 when released into the seawater. The insolubility of polyphosphate and divalent 
cations Mg2+/Ca2+ in seawater seem to suggest a pH triggering mechanism for the initial 
set [30].
The high amount of DOPA in the adhesive indicates that it readily undergoes 
oxidative covalent crosslinking. DOPA is known to be an adhesion promoter and 
facilitates solidification through di-DOPA, crosslinking in the byssal plaques of mussels 
[12]. The oxidation of DOPA occurs in alkaline sea water, giving rise to quinones that 
react further to crosslink adhesives proteins via aryl-aryl coupling (di-dopa formation) or 
possibly via Michael-type addition reaction with amine-containing protein residues 
[31-34]. This is also apparent when glue changes color, going from a whitish/clear 
appearance to a brownish coloring over time. DOPA is stable at pH 5 and converts to o- 
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Figure 1.3 Representative glue protein sequences. A) Sequence of polyacidic Pc3B. B) 
The serine residues (S) are more than 95% phosphorylated on the hydroxyl sidechain. 
The tyrosines (Y) are hydroxylated into DOPA residues. C) Sequence of polybasic Pc2. 
D) Structure of histidine (H) and lysine (K) residues with amine sidechains.
1.3 Biomimetic Complex Coacervate Adhesive
1.3.1 Sandcastle Worm Adhesive Complex Coacervate Model
The compositions of the sandcastle worm adhesive, proteins consisting of 
oppositely charged polyelectrolytes at physiological pH, indicate a model based on 
complex coacervates [20]. This model explains the foamy structure, fluid character, low 
interfacial tension, and cohesive properties of the water-borne underwater adhesive of the 
sandcastle worm [20].
1.3.2 Complex Coacervate
In a colloidal system, separation of a liquid into two phases is called Coacervation 
[35]. The denser phase in the colloid is called the coacervate, while the other phase is the 
equilibrium solution. In the aqueous solution of two polymers, phase separation can occur 
if there is an electrostatic attraction. A complex coacervate is formed when coacervation 
occurs due to two oppositely charged colloids [36] (Figure 1.4). They could be positively 
and negatively charged macroions, such as polyelectrolytes, with balanced charges. The 
two phases coexist and are immiscible in solution. The coacervate phase, or the polymer- 
rich phase, is an isotropic liquid that contains amorphous particles that move relatively 
freely to each other. The second phase, known as the supernatant, is a very diluted phase. 
The two macroions are surrounded by a double layer, a region with increased 
concentration of counterions, with lower energy (the average distance between positive 
and negative charges is smaller than that between positives or between negatives), and 
low entropy (small ions have less translational freedom) [37]. When the two macroions 
mix, the double layer is destroyed and counterions are released in the form of salt, which 




Figure 1.4 Complex Coacervate Formation. A) Mixing solution of polycation and 
polyanions can lead to associative phase separation and formation of complex coacervate 
[37], B) Coacervate/supernatant after centrifugation of coacervate system: BSA-F 
(bovine serum albumin) + Poly(diallyldimethylammonium chloride), at pH 9.5 and I = 
0.1 M NaCl [38],
coacervation [37].
Tiebackx [39] was the first to notice the coacervation phenomena in 1911. But it 
was Bungenberg de Jong [40] and Kruyt [41] who first systematically studied it on a gum 
arabic-gelatin coacervate, and named it complex coacervate. There are many theories and 
models, like Voorn-Overbeek theory [42-45] (gelatin/acacia coacervate), Veis-Aranyi 
“dilute phase aggregate model” [45] (albumin/gelatin coacervate), Nakajima-Sato Model 
[46], and Tainaka model [47-48], which have tried to explain the coacervate process. 
Burgess tried to compare and resolve a lot of contradictions that exist in coacervates [49]. 
The complex coacervate formation is dependent on molecular weights, concentrations, 
and ratio of two interacting polyions and on the ionic strength, pH, and temperature of the 
media [49]. All of the theories agree on the suppression of coacervation at high ionic 
strength. The random coil configuration of both polyions plays an important role. The 
Voorn-Overbeek theory studied the gelatin/acacia coacervates and explained that the 
electrical attractive forces tend to accumulate on charged polyions and the entropy effects 
tend to disperse these forces. The bundles of oppositely charged polyelectrolytes 
associate together due to these electrostatic forces to form a coacervate. The loops 
between polymers entrap water in the coacervate, which gives rise to entropy, which 
allows the number of possible macromolecule arrangements to occur. According to 
Voorn and Overbeek a random coil of the polyions is necessary, if the polymers were 
completely folded, no water could be entrapped, and coacervation would be unlikely. The 
distributive nature of electrostatic interaction allows for overall electrical neutrality in the 
coacervate, yet the molecules are free to move around in the liquid phase [49]. The Veis- 
Aranyi model considers coacervates a two-step process rather than a spontaneous
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process. They explain upon mixing of oppositely charged polyions, aggregates of low 
configurational entropy form, in which “coacervate sols” rearrange to form the 
coacervate phase [49]. This rearrangement can take from hours to days and is driven by 
gain in configurational entropy upon the formation of randomly mixed concentrations of 
coacervate phase and dilution of aggregate phase.
Despite the contradictions all these theories could agree to the following about 
complex coacervates: complexes began to form before the phase separation occurs, even 
if there is an excess of one polyelectrolyte, the complex are only modestly charged, salt 
has a dissociating effect on the complexes, salt concentration is equal in the coacervate 
and supernatant phase, and in coacervate there is clear mobility of both polymers. By one 
polyelectrolyte carrying a positive and one carrying a negative charge restricts the 
complex coacervate formation occurring at a finite pH range. The coacervation 
phenomena are entropically driven. The coacervate and supernatant phases must be 
neutral or near neutrality, where this neutral complexes resembling gas-liquid separation 
in colloids. [50-51]
There are many reasons that contribute to the stability of complex coacervates. 
The coulomb attraction (ion pairing) and the entropy increase due to counterion release 
are major driving forces for the formation, which includes hydrophobic effect, hydrogen 
bonding, and hydration forces [52]. Coacervates have low interfacial tension in water (~
0.0005 dynes/cm) and exhibit ~ 0° contact angles [41]. The interfacial tension is 
important and is directly related to interaction between the macroions. In comlex 
coacervate core micelles the interfacial tension drives the formation of micelles and can 
be used to predict the critical aggregation concentration [53]. The interfacial tension is
14
very sensitive to the added salt [54].
There are many examples and applications that the complex coacervates exist in, 
in nature as well as industry. DNA is packed into small volume of DNA-binding proteins, 
in both eukaryotic and prokaryotic cells. This DNA compaction is largely due to the 
electrostatic attraction between oppositely charged macroions [55]. This phase separation 
can also occur in polyelectrolytes and oppositely charged colloids like micelles [56], 
proteins [57], and dendrimers [58]. In industry, coacervates have found applications in 
protein purification [59], drug and enzyme immobilization [60], cosmetic formulations 
[61], pharmaceutical microencapsulation [62], and in trapping organic plumes [63-64].
The Pc1, Pc2, and Pc3 proteins of the sandcastle worm are water-soluble 
polyelectrolytes. If the worm secretes them sequentially, it would be risky to loose them 
by dilution into the surrounding seawater [20]. That is why the complex coacervate 
method was proposed as a model for the worm. Coacervates can absorb the water from 
wet surfaces, and with their low interfacial tension they tend to spread easily over wet 
surfaces [65].
1.3.3 Synthetic Analog: Complex Coacervate Adhesive
Inspired by the sandcastle worm a synthetic analog to the underwater adhesive is 
made. The P. californica adhesive is of particular interest to us because of its ability to 
bond to wet surfaces, versatility in bonding to various particle substrates, and its 
effectiveness at low mortar-to-filler weight ratios [66-67]. This water-borne glue is able 
to displace surface bound water from the substrates, which is a big insight into its strong 
interfacial adhesion properties [13]. Its ability to hold together a robust shell capable of 
holding strong high-energy environments makes it an intriguing model for biomimetic
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adhesive [13].
The synthetic adhesive was formed by the method of complex coacervation of 
glue protein analogs of the sandcastle worm [13-14]. The oppositely charged Pc3 and 
Pc1 protein analog polymers were made, containing the phosphate and amine sidechains, 
using a similar ratio to that found in the worm (Figure 1.5). These proteins were easily 
copied with poly(meth)acrylates. The copolymers were water-soluble, inexpensive, and 
scalable. The Pc3B polymethacrylate also contained the catechol, as shown in Figure 1.5. 
When mixed under the set conditions, the aqueous polymer solutions condensed into a 
complex coacervate at neutral pH [13]. The complex coacervate adhesive was chemically 
crosslinked through the oxidation of DOPA by NaIO4 to convert the catechol to 
dopaquinone [68].
This biomimetic complex coacervate adhesive was designed for gluing bone 
together. Our lab group was able to show that using the synthetic complex coacervate 
adhesive attained 40% strength of commercially available cyanoacrylate glue [13]. This 
water-borne adhesive has an advantage over other commercially available adhesives; our 
adhesive can be injectable under water and adheres to wet surfaces, whereas all glues fail 
under water eventually.
1.3.4 Multipart Copolyelectrolyte Model Sandcastle Worm Adhesive
Recent work on the sandcastle worm shows that complex coacervation may not be 
playing a role in the natural adhesive formation [19]. It would be difficult for the worm to 
preform and premix the complex coacervate before secretion. The worm glue, instead, is 
a multipart polyelectrolyte adhesive. The oppositely charged proteins are packaged 
separately in highly concentrated granules, which are mixed as they leave the building
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Figure 1.5 Synthetic analogs of glue proteins. A) of the Pc3B polymethacrylate analog 
copolymer. B) Structure of the polyamine analog copolymer. The analog polymers are 
random copolymers synthesized by free radical polymerization [30]. Reprinted from 
Advances in Colloid and Interface Science, 167 (1-2), R. J. Stewart, C. S. Wang, and H. 
Shao, Complex Coacervates as a Foundation for Synthetic Underwater Adhesives, 
85-93, Copyright 2011, with permission from Elsevier.
organ and have a “burst” release effect once in contact with seawater. Homogeneous 
granules contain sulfated macromolecules and Pc2/Pc5 protein. The heterogeneous 
granules contain Pc3A and Pc3B proteins along with divalent cations, Pc1 and Pc4, with 
both granules containing DOPA. Once they leave the building organ, the proteins form 
solid foam and fully set within 30 sec. The sandcastle worm would not have enough time 
to form a complex coacervate it is more a multipart copolyelectrolytes.
1.4 Fetal Defects
The water-borne synthetic complex coacervate adhesive can be used in many 
fields of medicine. Adhering or binding soft tissues in wet environments is a major 
challenge. Most soft tissue adhesives are designed for dry applications that ultimately fail 
under water due to fluid in the joints. Applying the adhesive on wet surfaces and 
controlling its solidification is difficult. One such field where advanced soft tissue 
adhesive could be used in is gluing fetal tissue, in utero.
1.4.1 The Need for Fetal Tissue Adhesives
Increased use of ultrasound scanning since the 1980s has led to the early detection 
of fetal defects. Advanced medical diagnostic techniques are able to detect congenital 
malformations earlier in pregnancy. Early detection has given rise to a large number of 
treatments and interventions. Fetal surgery is one of those promising therapeutic options 
for number of congenital malformations [69], where the field has grown from a concept 
to a medical subspecialty today [70]. In the past 2 decades advances have been made in 
fetal surgical interventions and fetal therapy by nonoperative means [69]. Fetal imaging, 
diagnosis, and anesthesia have allowed fetal interventions to be a vital tool for patients
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who would otherwise face morbidity and mortality [70]. This makes minimal access fetal 
surgery possible where the fetal condition determines the invasiveness of the surgery. 
This is possible with laparoscopic surgery and fetoscopy.
Fetal surgery, although very successful in a growing number of malformations, is 
limited in treatment due to conditions like preterm labor, chorionamniontic membrane 
separation, altered fetal homeostasis, and iatrogenic preterm premature rupture of the 
fetal membranes (iPPROM) [71]. Even in invasive procedure like fetoscopy, iPPROM is 
a big complication, resulting in amniotic fluid leakage. Fetoscopy is an endoscopic 
procedure during pregnancy that gives access to the fetus. Once the patient is diagnosed 
with iPPROM, the mother can barely carry the fetuses for longer than a few months [72]. 
In fetoscopic procedures there is a 6-45% rate where iatrogenic preterm premature 
rupture of the fetal membrane occurs [73]. All these associated risks involved give rise to 
morbidity and death, which compromises the expected benefits of such methods to begin 
with [73].
Many attempts have been made to close the ruptured fetal membranes but have 
been unsuccessful. The natural healing of human fetal tissue appears to be slow, if not 
absent, even in very small fetoscopic punctures. Histological studies after fetoscopic 
puncture defect of human membranes show no healing or growth in the tissue [74]. New 
innovative techniques to plug up the fetoscopic access site are being tested [75-76]. 
Intraamniotic injection at the puncture site of maternal platelets mixed with fibrin 
cryoprecipitate (amniopatch) has been successful, but the high platelets in the amniopatch 
has accounted for otherwise unexplained fetal deaths [77]. Dry collagen and gelatin plugs 
or liquid blood-derived sealants are being studied [78-79]. Cyanoacrylate adhesives, well
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known for strong adhesion in surgical and traumatic wound repair [80], damaged the fetal 
tissue and disrupted the membrane structure [73, 81]. Commercially available 
Dermabond and Histoacryl adhesives were cytotoxic when in contact with fetal 
membranes [73]. Other PEG-based hydrogel polymers like SprayGel failed to bond to 
fetal membranes under wet conditions [73]. Adhesive that can glue in wet conditions, to 
plug the amniotic sac to prevent amniotic fluid leakage, and is biocompatible is needed. 
The iPPROM after a fetal surgery or invasive prenatal procedure is an unsolved clinical 
problem [73].
1.5 Aim of This Research
Adhesives for soft tissue repair, more so for sealing fetal defects, is needed. 
Bonding tissue is a major challenge in wet environments, and having something that 
adheres in utero and biocompatible is difficult. The aim of this research is to develop a 
bioadhesive, inspired by the sandcastle worm, to seal fetal defects, in particular designing 
the glue for the applications in two fetal conditions: twin-to-twin transfusion syndrome 
(TTTS) and spina bifida. The twin-to-twin transfusion syndrome is the unequal sharing of 
maternal blood in twin pregnancies. This syndrome requires fetoscopic laser surgery as 
one of its treatments, and an adhesive to plug the fetoscope-punctured membrane is 
needed. The second condition spina bifida is a congenital disorder, where the neural 
tissue of the fetus is exposed to the amniotic fluid causing neurological defects at birth. 
An adhesive patch to cover the neural tissue with a minimally invasive procedure, until 
birth, a more complex closure, can prolong a better outcome when the baby is born 
[82-83]. The objective of this work is to design a synthetic complex coacervate adhesive 
that can fit both of these applications, in utero repair. The bioadhesive has to be stable
20
21
and have the ability to be used in the practical application of the adhesive in these 
conditions.
1.5.1 Twin-to-Twin Transfusion Syndrome
Twin-to-twin transfusion syndrome (TTTS) is a condition that is diagnosed during 
pregnancy by ultrasound. In pregnancies of twins, one-third of twins are monozygotic 
(MZ), and three-fourths of the MZ twins have presence of monochorionic diamniotic 
(MCDA) [84]. Twin pregnancies of MCDA placenta are at a high risk of TTTS that 
affects about 8-10% of pregnancies [85-87]. Currently TTTS occurs in approximately 
1-3 per 10,000 births [88]. With TTTS, the two fetuses have unequal sharing of the 
mothers blood, which leads to asymmetrical fetal growth and fetal mortality, if left 
untreated. They share a placenta that contains abnormal blood vessels, where the blood 
supply from one baby to another is disproportional. The donor twin fetus receives less 
blood, which slows down its growth, and the recipient twin has excess blood, causing too 
much strain on the heart of the fetus. TTTS is a progressive disease in which sudden 
deterioration can occur leading to death of the fetuses, risk of miscarriage, brain damage, 
and morbidity [89-90]. This condition is diagnosed normally in second trimester of the 
pregnancy. Fetoscopic laser ablation is an effective treatment for TTTS, where a laser 
through a fetoscope coagulates the blood vessels as shown in Figure 1.6.
The survival rates after fetoscopic laser surgery of TTTS are 50-70% [92]. The 
laser surgery for TTTS is a fetoscopic procedure with insertion of laser into the scope 
[70]. The risk of iPPROM is 10-30% procedure-associated fetal loss with laser [84, 93]. 
Sealing the defect site after fetoscopic laser ablation can reduce the perinatal morbidity 
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Figure 1.6 Fetoscopic laser ablation for twin-to-twin transfusion syndrome treatment 
[91], Reprinted with permission from so+gi.
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defect for this application can be a model sealing all fetal tissues for other conditions.
1.5.2 Spina Bifida
Spina Bifida, “split spine,” is a developmental congenital disorder where the fetus 
neural tube is left unclosed, affecting 1,500 babies a year [94]. Myelomeningocele 
(MMC) is the most severe case of Spina Bifida (Figure 1.7), where the closure defect 
protrudes and bulges out of the posterior spinal column. The MMC is a severe 
malformation that can result in disability at birth and be a major challenge to fix in fetal 
repair [95]. The condition is detected 16 to 20 weeks of pregnancy. The exposed neural 
tissue undergoes progressive damage with advancing gestation age due to being in 
contact with amniotic fluid [96]. The fetus also develops a Chiari II condition of the 
brain, resulting in irreversible neurological impairments at birth, from the pressure 
disturbance and loss of cerebrospinal fluid [97]. At birth a number of defects result due to 
MMC: paraplegia, sphincter incontinence hydrocephalus, cranial nerve disturbances, 
respiratory problems, and death [98].
The treatment for MMC repair is challenging, with high risk of maternal and fetal 
morbidity and mortality. The surgical procedure could face difficulties like iPPROM, 
uterine rupture, maternal hemorrhage, and hysterectomy. The first intrauterine surgery 
repair of fetal myelomeningocele was performed on humans at Vanderbilt University 
Medical Center in Nashville, Tennessee, USA, in 1994 [100-101]. It was a very difficult 
and risky procedure, with a lot of research underway to improve the method of treatment 
[102]. The intrauterine surgery requires the defect to be closed in multilayer fashion, with 
neural dissection, dural closure, and suturing of the spinal cord, which increases the 
operating time as well [103]. Animal studies have shown that repair of neural tube defect
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Figure 1.7 Illustration of a child with Myelomeningocele (MMC). [99] Reprinted with 
permission from so+gi.
in the womb could result in a less severe hindbrain and spinal cord injuries at birth [82,
83, 104]. The multilayer closure has been reported in fetoscopic repair, but the method is 
technically very demanding and time consuming [102]. Less invasive surgical technique 
that would just cover up the defect till birth, followed by a more complex MMC repair 
could be an effective treatment. An adhesive patch to cover up the defect through a 
minimally invasive method would be an ideal scenario for this application. Currently 
there is nothing out there that can adhere the patch under aqueous conditions to the spinal 
column of the fetus.
1.6 Outline of This Thesis
This thesis consists of research in developing a synthetic complex coacervate 
adhesive for sealing fetal defects in utero. The biomimetic adhesive is designed for two 
applications of TTTS and spina bifida. The research work consists of preliminary studies 
to prove that the synthetic complex coacervate adhesive can be used to seal fetal 
membranes, followed by a more in depth approach to making an adhesive composition 
that is more stable and used in practical applications and taking this adhesive from design 
and synthesis to animal studies.
In Chapter 2 a multiphase adhesive complex coacervate with increased bond 
strength was developed. Polyethylene glycol diacrylate was entrapped into the 
coacervate, creating a second polymer network via crosslinking, which helps aid in 
increased shear bond strength. The rheological flow behavior of the complex coacervate 
adhesive was extensively studied. Shear-thinning behavior without destructing the 
coacervate network is an important property for an injectable system.
In Chapter 3 the high bond strength adhesive was tested in conjunction with a
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fetal membrane patch to model the adhesive as a potential sealant for fetoscopic 
procedures. The adhesive was tested with the in vitro model, mimicking the wall-fetal 
membrane. The cytotoxicity of the adhesive was tested with direct contact to human fetal 
membranes. This preliminary study was key in taking the adhesive to the next phase of 
animal studies.
In Chapter 4 a complex coacervate adhesive was developed using methacrylated 
polyphosphate and polyamine polymers. The synthesis methods used were explained. 
Aqueous polymerization and grafting methods were evaluated. Reversible Addition- 
Fragmentation Chain Transfer (RAFT) was used for polyamine polymer. The complex 
coacervate system was studied to tailor the properties to the application.
In Chapter 5 the mechanical properties of the methacrylated complex coacervate 
adhesive was tailored to the TTTS application. A chemically crosslinked coacervate 
adhesive was designed for this application. The crosslinking kinetics, bond strengths, and 
stability were studied. The sterile complex coacervate adhesive packets were prepared for 
the pig animal studies.
In Chapter 6 the mechanical properties of the methacrylated complex coacervate 
adhesive was tailored for the spina bifida application. A photocrosslinked coacervate 
adhesive patch was designed for this application. The crosslinking kinetics, bond 
strengths, and swelling behavior were studied. The sterile complex coacervate adhesive 
packets were prepared for sheep animal studies.
In the concluding chapter findings are summarized. The impact of our study and 
its contribution to soft tissue adhesives, more specifically fetal tissue adhesive is 
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CHAPTER 2
MULTIPHASE ADHESIVE COACERVATES INSPIRED 
BY THE SANDCASTLE W ORM
2.1 Abstract
Water-borne, underwater adhesives were created by complex coacervation of 
synthetic copolyelectrolytes that mimic the proteins of the natural underwater adhesive of 
the sandcastle worm. To increase bond strengths, we created a second polymer network 
within cross-linked coacervate network by entrapping polyethylene glycol diacrylate 
(PEG-dA) monomers in the coacervate phase. Simultaneous polymerization of PEG-dA 
and crosslinking of the coacervate network resulted in maximum shear bond strengths of 
~ 1.2 MPa. Approximately 40% of the entrapped PEG-dA polymerized based on 
attenuated total reflectance-Fourier transform infrared spectroscopy. The monomer-filled 
coacervate had complex flow behavior, thickening at low shear rates and then thinning 
suddenly with a 16-fold drop in viscosity at shear rates near 6 s-1. The microscale 
structure of the complex coacervates resembled a three-dimensional porous network of 
interconnected tubules. The sharp shear thinning behavior is conceptualized as a 
structural reorganization between the interspersed phases of the complex coacervate. The
Adapted from a pre-peer-reviewed version with permission from S. Kaur, G. M. 
Weerasekare, R. J. Stewart, “Multiphase adhesive coacervates inspired by the Sandcastle 
worm,” ACSAppl. Mater. Inter., 3 [4] 941-4 (2011). Copyright 2011 American Chemical 
Society.
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bond strength and complex fluid behavior of the monomer-filled coacervates have 
important implications for medical applications of the adhesives.
2.2 Introduction
Adhesive bonding in watery environments with common synthetic adhesives is 
confounded, in general, by poor interfacial adhesion leading to eventual failure by 
infiltration of water into the joint. Aquatic environments are populated with diverse 
organisms that have evolved a multitude of workable solutions to the underwater 
adhesion problem. Natural underwater adhesives have therefore been studied as potential 
sources of materials or concepts with the goal of creating or improving synthetic 
adhesives for wet applications, including repair of living tissues. One such model is the 
underwater adhesive of the Sandcastle worm (Phragmatopoma californica), a marine 
polychaete [1-3]. The Sandcastle worm employs an ingenious strategy to construct 
composite mineralized shells; the mineral phase is gathered from its environment 
preformed as sand grains and shell fragments that are then glued together with small dabs 
of an underwater adhesive [1].
The sandcastle worm glue is comprised of oppositely charged proteins and 
divalent cations [2, 3]. Copolyelectrolytes with the same chemical side chains 
(phosphates and amines) and in the same proportions as the natural proteins were 
synthesized. When mixed under the right conditions, the synthetic copolyelectrolytes 
condensed into fluid complex coacervates [4, 5]. As the basis for underwater adhesives, 
complex coacervates have several ideal properties: the dense, phase-separated fluids sink 
in water, are sufficiently cohesive that they do not mix with water on a time scale of 
several minutes, and readily adhere to wet surfaces, all of which allows the adhesive to
stay in place where it is applied underwater. The adhesive becomes load-bearing by 
triggered solidification of the complex coacervate after application. The sandcastle worm 
glue sets within 30 s through pH-triggered solidification of a polyphosphorylated protein 
and Ca2+ and Mg2+ [2, 6]. The initial set is followed up over several hours by covalent 
crosslinking through 3,4-dihydroxy-L-phenylalanine (dopa) residues. Both the pH- 
triggered set and dopa-mediated crosslinking were replicated in biomimetic adhesive 
coacervates [4, 5].
Though the natural sandcastle glue is suitable for the dimensions and lifecycle of 
sandcastle worms, it is not particularly strong, around 300 kPa [7]. Biomimetic adhesives 
will have to be much stronger than the natural adhesive to find broad utility. 
Incorporation of micro- or nanophases into the bulk adhesive phase is a well-known 
strategy for increasing adhesive bond strengths [8]. Our strategy for incorporation of an 
additional phase into our biomimetic adhesive was to form the coacervate in the presence 
of a water-soluble neutral monomer, as a first example, polyethylene glycol-diacrylate 
(PEG-dA). Polymerizable monomers dissolved in the aqueous copolyelectrolyte 
solutions become incorporated into the dense coacervate phase, which is mostly water by 
weight. Polymerization created a second polymer network within the coacervated 
copolyelectrolyte network. The coacervate functioned, in effect, as a container for the 
polymerizable monomers that could be accurately delivered underwater before 
polymerization of the second internal polymer network was initiated.
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2.3 M aterials and Methods
2.3.1 Materials
All reagents were used without further purification unless noted otherwise. 
Phosphorous oxychloride (POCl3, 98%), 2-hydroxyethylmethacrylate (HEMA, 97%), and 
triethylamine (99%) were purchased from VWR. The 2,2’-azobisisobutyronitrile (AIBN) 
was purchased from Polysciences. Ultra filters Pellicon Ultracel Membranes by Millipore 
were used. N-(3-Aminopropyl) Methacrylamide, Hydrochloride, and Acrylamide 
(Chemzymes, ultra pure) were purchased from Polysciences. PEG-dA (Polyethylene 
glycol diacrylate, 760 Da) was purchased from sigma-aldrich.
2.3.2 Monomer Synthesis
2-(methacryloyloxy)ethyl phosphate (MOEP) was synthesized by adding 
phosphorus oxychloride (16.8g, 110 mmol) under argon to a stirred solution of 2- 
hydroxyethyl methacrylate (12g, 92 mmol) in toluene (340 mL). The reaction mixture 
was cooled to 0°C, and triethylamine (39 mL, 276 mmol) was added. The reaction 
proceeded at 0°C for 30 mins, then at room temperature for 6 hrs. The white solid 
precipitate was recovered by filtration. Water (240 mL) was added to the filtrate and 
stirred overnight. The two layers were separated, and the aqueous phase was acidified 
and then extracted with THF: Ether (1:2, 6x225 mL). The organic phases were 
combined, dried over Na2SO4, and solvent evaporated to obtain the product as a pale 
yellow oil (67%, 12.2g). 1H NMR spectroscopy (300 MHz, D2O) d 1.7 (3H, s), 4.0 (2H, 
m, POCH2), 4.2 (2H, m, POCH2CH2), 5.5 (1H,s) 6.0 (1H, s); 13C NMR (75 MHz, D2O) d 
17.4, 64.2 (d, 2Jp o c  = 8.3 Hz), 64.4 (d, J p o c c  = 5.5Hz), 127.2, 135.6, 169.4; 31P NMR 




Poly(MOEP-co-DMA) was synthesized as previously described [4] by free 
radical polymerization of MOEP and DMA initiated with AIBN in methanol. The 
polymerization proceeded at 55oC for 16 hours (Figure 2.1). The copolymer was 
precipitated with acetone and then washed twice with acetone to remove residual 
monomers. The polymer was then dissolved in water and ultrafiltered on pellicon 
ultracel membranes with MWCO 1000 kDa followed by filtration with MWCO of 5 kDa. 
The concentrations of phosphate and o-DHP side chains were determined by NMR and 
UV/vis spectroscopy and were 76 and 19 mol%, respectively. The MW (64 kDa) and PDI 
(2.8) of the copolymer were determined by size exclusion chromatography (SEC) on an 
AKTA FPLC system with a Superose 6 HR 10/300 column (GE Healthcare) in 0.05 M 
phosphate and 0.15 M NaCl (pH 7.4).
Poly(acrylamide-co-aminopropyl methacrylamide) was synthesized by free 
radical polymerization of 90 mol% acrylamide and 10 mol% N-(3-amino-propyl) 
methacrylamide hydrochloride (Figure 2.2), as previously described [4]. The copolymer 
was purified by dialysis for 3 days and lyophilized. The amine concentration (mol/mg) 
was determined with ninhydrin using glycine as the standard. The MW and PDI, 
determined by SEC in 0.5 M NaCl and 0.1 M NH4CH3CO2 on Superdex 200 column (GE 
Healthcare), were 288 kDa and PDI 1.36.
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Figure 2.1 Synthesis schematic of Poly(MOEP-co-DMA) polymer, polymerized by free 
radical polymerization.
n h 3 Cl n h 3c i
Figure 2.2 Synthesis schematic of Poly(acrylamide-co-aminopropyl methacrylamide) 
polymer, polymerized by free radical polymerization.
2.3.4 Coacervate Formation
PEG-dA was dissolved in degassed DI water at the desired concentration (0-25 
wt%). Poly(acrylamide-co-aminopropyl methacrylamide) and poly(MOEP-co-DMA) 
were dissolved in separate PEG-dA solutions at a final concentration of 5 wt%. The 
poly(MOEP-co-DMA) PEG-dA solution also contained a 0.2 molar ratio of Ca2+ to 
phosphate side chains. The copolymer solutions were adjusted to pH 7.4±0.2 with 
NaOH. The poly(acrylamide-co-aminopropyl methacrylamide) PEG-dA solution was 
added dropwise while stirring to the poly(MOEP-co-DMA) PEG-dA solution to a molar 
ratio of 0.6 amine side chains to phosphate side chains. Within a few minutes a turbid 
coacervate settled out of solution.
2.3.5 Mechanical Testing
The adhesive PEG-dA filled coacervates were cross-linked through the o-DHP 
side chains of the polyphosphate and/or by polymerizing PEG-dA. o-DHP was 
oxidatively cross-linked by adding 1 equivalent of NaIO4. To slow the oxidation of o- 
DHP side chains, in order to allow better control of the setting reaction, a sugar (1,2-O- 
Isopropylidene-D-glucofuranose, 98%) molecule was used to prepare an aqueous 
NaIO4/sugar complex solution (100 mg/mL) with a NaIO4:Sugar of 1:1.2 dissolved in 
water. PEG-dA was polymerized with 3.5 mol% ammonium persulfate (APS) and 5.2 
mol% N,N,N’,N’-tetramethylethylenediamine (TEMED). Immediately after adding 
NaIO4, APS, and TEMED, 20 ^l of coacervate was added to a wet 0.5 x 5 cm cleaned 
and polished Al adherend. A second wet Al was placed on the first with a 14-20 mm 
overlap, secured with a stainless steel clip, and submerged in water for 20-24 hours at 
22-24°C. For each test condition 4-6  specimens were prepared. The shear strength of
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the bonds were determined on a material testing system (Instron) with a 500 N load cell, 
crosshead speed 0.2 mm min-1, while fully submerged in a temperature-controlled water 
bath.
2.3.6 Dynamic Rheology
Flow experiments were done on a stress-controlled rheometer (TA Instrument, 
AR 2000ex) using a 20 mm, 4° cone and plate, gap of 114 ^m, and at 25°C with 150 |iL 
coacervate samples. All rheology experiments were repeated with three independently 
prepared coacervate samples.
2.3.7 ATR-FTIR
Attenuated Total Reflectance-Fourier Transform Infrared Microscopy (ATR- 
FTIR, FTS 6000 Spectrometer BioRAD) was used to measure the amount of PEG-dA in 
coacervates as well as the conversion of polymerization. The scans were made on ZnSe 
reflective crystal by placing 50 ^l of coacervate and running 30 scans per spectrum. 
Standard PEG-dA solutions of known concentration in water were scanned to get a 
standard curve (Figure 2.3A). Peak 1415 cm-1, corresponding to the acrylate group in 
PEG-dA, was used to fit a linear model of normalized peak area versus known 
concentration (Figure 2.3B). This standard curve fit was used to analyze the amount of 
PEG-DA in coacervates. Each sample was measured three times to get an average value.
2.4 Results and Discussion
Coacervates were formed with 2-(methacryloyloxy) ethyl phosphate dopamine 
methacrylamide (poly(MOEP-co-DMA)), poly(acrylamide-co-aminopropyl





















Figure 2.3 ATR-FTIR (A) ATR-FTIR of PEG-dA in water solutions of set 
concentrations were scanned to generate a standard curve. (B) Peak 1415 cm-1 was used 
to fit a linear model of normalized peak area vs. known concentration.
nominal wt% concentrations of 0, 5, 10, 15, 20, and 25 PEG-dA (MW 700 g/mol). Dense 
complex coacervates phase separated from the solutions. The concentration of PEG-dA 
entrapped in the coacervate phase was determined by Attenuated Total Reflectance- 
Fourier Transform Infrared Microscopy (ATR-FTIR). The absorbance peak at 1415 cm-1 
was compared to the 1415 cm-1 acrylate groups of standard solutions of PEG-dA in water 
(Figure 2.4A) [9, 10]. On average the PEG-dA concentration in the coacervate was 73% 
of the initial concentration in solution. Above 25 wt% PEG-dA the coacervates were too 
viscous to work with conveniently. Free radical polymerization of entrapped PEG-dA 
was initiated by adding ammonium persulfate (APS) and tetramethylethylenediamine 
(TEMED) to the complex coacervate. The extent of PEG-dA polymerization within the 
coacervate was determined from the 1415 cm-1 ATR-FTIR peak corresponding to the 
acrylate functional group (Figure 2.4B). The complex coacervate containing 11.4 wt% 
PEG-dA reached ~40% conversion after 24 hr.
The shear bond strengths of the PEG-dA filled adhesive coacervates were 
determined in lap shear tests with polished aluminum adherends. Cross-linking of the 
coacervate network through the o-dihydroxyphenyl sidechains of poly(MOEP-co-DMA) 
and the amine side chains of poly(acrylamide-co-aminopropyl methacrylamide) was 
initiated by addition of NaIO4. Free radical polymerization of PEG-dA was initiated 
simultaneously by addition of APS and TEMED. Immediately after initiation the 
coacervates were applied to wet Al adherends. The bonds were cured for 24 hours and 
fully submerged in water (22°C) before loading to failure on a material testing system. 
The maximum bond strengths increased with increasing PEG-dA (Figure 2.5), nearly 







Figure 2.4 ATR-FTIR Study of 11.4 wt% PEG-dA complex coacervate. (A) Spectrum of 
acrylate group at 1415 cm-1 (j indicating peak of decreasing over time after 




Figure 2.5 Shear bond strength of PEG-dA filled complex coacervates. The coacervate 
network was oxidatively cross-linked and PEG-dA polymerized by the simultaneous 
addition of NaIO4 and APS/TEMED, respectively. Bonds were cured under water for 24 
h at 25°C. Gray column: coacervate filled with 15 wt% nonacrylated PEG and cured with 
NaIO4 and APS/TEMED. Error bars: ± s.d. (n = 5).
with 17.7 wt% PEG-dA. Maximum loads were ~1.2 MPa, more than four times higher 
than estimated bond strengths of the natural sandcastle glue [7] and mussel adhesive 
plaque byssal thread assemblies [11]. The shear modulus, approximately 25 MPa, was 
not statistically different between any of the PEG-dA concentrations. To confirm the 
increased bond strength was due to polymerization of PEG-dA, we formed coacervates 
with 15 wt% nonacrylated PEG (MW 400 g/mol) and treated with NaIO4 and 
APS/TEMED. The underwater bond strengths were 211 +/- 39 kPa, less than 25% of the 
PEG/coacervate bond strengths.
The flow behavior is of critical importance for adhesives based on complex fluids 
such as coacervates. For medical applications, the viscosity should be sufficiently high at 
low shear rates that the adhesive does not flow away from the application site, yet low 
enough at high shear rates that it can be conveniently applied through a narrow gauge 
cannula, or catheter, without high pressure. At the same time, it is imperative to 
recognize shear-induced, irreversible structural transitions at high shear rates that may 
compromise cohesive bond formation. The viscosities of the adhesive complex 
coacervates containing 0 and 11.4 wt% PEG-dA were investigated as a function of shear 
rate using a cone and plate geometry (Figure 2.6). At low shear rates (0.01 s-1) the 
viscosity of the 11.4 wt% PEG-dA filled coacervate (13.8 +/- 6.2 Pa s) was substantially 
higher than the complex coacervate with 0 wt% PEG-dA (0.9+/-0.1 Pa s). With 
increasing shear rate the PEG-dA-filled coacervates first thickened, then steadily thinned 
until a sudden 16-fold drop in viscosity occurred at a shear rate of 6 s-1 (Figure 2.6A). 
The shear thinning behavior was reversible; viscosity recovered with little hysteresis as 







Figure 2.6 Flow curves of complex coacervates under steady shear. (A) Filled 
coacervates of 11.4 wt % PEG-dA: low to high shear rate (closed square) and high to low 
shear rate (open square). (B) Unfilled coacervate: low to high shear rate (closed circle), 
and reverse (open circle). Symbols and error bars are the average viscosity and s.d. at 
each shear rate of three independent coacervate samples.
well but did not display a similar sudden sharp drop in viscosity (Figure 2.6B).
The flow curves of the complex coacervate containing PEG-dA monomers are 
similar to other coacervate systems that have been investigated rheologically. Whey 
protein and gum arabic coacervates displayed a similarly abrupt shear-thinning transition 
that was accompanied by an increase in turbidity [12]. The transition was reversible. 
Polycation/mixed micelle coacervates, above a certain temperature, underwent a dramatic 
shear rate-dependent drop in viscosity before visibly phase separating [13]. In both 
cases, the visible changes suggest the abrupt shear-thinning events were due to 
microscale structural reorganizations of the interspersed phases of the complex 
coacervates. The quiescent nanoscale molecular structure of the complex coacervates 
were conceptualized as beads on compacted strings: globular whey proteins on gum 
arabic molecules in the first case, polyanionic mixed micelle beads on polyamine strings 
in the second case [14]. Abrupt shear thinning was attributed to shear-induced elongation 
of the beaded string structures, resulting in increased lateral intercomplex associations 
and coalescence of nanocomplexes into dense microphases.
The rich and complex flow behavior of the PEG-dA-filled coacervates suggests 
that similar shear-induced, reversible structural reorganization may occur within the 
PEG-dA filled coacervates. Unsheared complex coacervates with and without PEG-dA 
were frozen, lyophilized, and examined by scanning electron microscopy (SEM). The 
coacervates had a porous three-dimensional network of tubular structures (Figure 2.7) 
reminiscent of the sponge-like network of tubules observed in other complex coacervates 
by cryo-TEM [15]. There were no structural differences apparent between coacervates 
with and without PEG-dA monomers. Based on the flow behavior and SEM
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Figure 2.7 SEM Images of fractured surfaces of lyophilized complex coacervates. (A) 
700x, (B) 5000x.
micrographs, a conceptual diagram of the PEG-dA-filled complex coacervate before and 
after the shear-induced structural transition is shown in Figure 2.8. The quiescent 
coacervate is pictured as a dense, interconnected, colloid-rich network interspersed within 
a watery, colloid-depleted network containing PEG-dA (Figure 2.8A). Above a critical 
shear rate, the interspersed networks may undergo shear-banding (Figure 2.8B), a 
phenomenon in which the components of a complex fluid phase separate into distinct 
bands under shear [16-18].
The practical significance of the shear thinning of the PEG-dA-filled coacervates 
is demonstrated in Figure 2.9, a still image from a supplemental video. A 11.4 wt% 
PEG-dA-filled coacervate was loaded into a 1 mL syringe fitted with a 27 gauge cannula. 
Despite the relatively high initial viscosity, it took little manual effort to eject a fine 
cohesive thread of the PEG-dA-filled coacervate under water. The shear rate during 
ejection was estimated to be 750 s-1. The water-borne threads were denser than water, 
maintained their shape, and adhered where they contacted the glass surface. The 
coacervate also adhered when applied underwater to vertical glass surfaces. In principle, 
the coacervated threads, or any pattern of threads, can be cross-linked in place by 
coinjection of polymerization initiators. The ability to accurately deliver adhesive 
through a fine cannula or catheter will allow precise and less invasive repair of bone 
fractures [19] and other tissues.
2.5 Conclusion
In summary, the bond strength of the biomimetic adhesive coacervates was 
substantially improved to well above the estimated bond strength of natural bioadhesives 
by incorporating a second polymer network into the coacervate network. The viscous
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high shear rate
Figure 2.8 Conceptual diagram of the structure of the PEG-dA filled complex 
coacervate. (A) In the quiescent state, the electrostatically associated nanocomplexes 
form a fluid, interconnected, three-dimensional network. An aqueous phase containing 
PEG-dA is interspersed within the pores of the connected network of nanocomplexes. (B) 
At a critical shear rate, the nanocomplexes may be elongated leading to additional lateral 
interactions and a second, reversible macrophase separation.
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Figure 2.9 Image of a 11.4 wt % PEG-dA filled coacervate loaded into a 1 mL syringe 
with a 27 gauge cannula, being ejected under water.
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PEG-dA filled coacervate could be easily ejected through a fine gauge cannula as a result 
of reversible shear thinning. The threads maintained their form underwater and adhered 
to wet glass surfaces. The successful incorporation of high concentrations of water- 
soluble monomers demonstrated that, in principle, almost any water-soluble molecule can 
be contained in a complex coacervate and precisely delivered in a wet environment, 
including noninvasive delivery into the body. Such properties merit further evaluation of 
the filled adhesive coacervates as injectable drug delivery depots in addition to their 
potential as wet field medical adhesives. Work in progress is focused on incorporating 
more and different types of nano- and microphases into complex coacervates to further 
improve underwater bond strengths.
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CHAPTER 3
FETAL MEMBRANE PATCH AND BIOMIMETIC 
ADHESIVE COACERVATES AS A SEALANT 
FOR FETOSCOPIC DEFECTS
3.1 Abstract
Iatrogenic preterm premature rupture of membranes after fetoscopic procedures 
affects 10-47% of patients, secondary to the nonhealing nature of membranes and the 
separation of layers during the entry. In this study we developed an in vitro model to 
mimic the uterine wall-fetal membrane interface using a water column with one end and 
sealed with human fetal membranes and poultry breast, and a defect was created with an
11 French trocar. In addition, a fetal membrane patch in conjunction with multiphase 
adhesive coacervates modeled after the sandcastle worm bioadhesive was tested for 
sealing of an iatrogenic defect. The sealant withstood an additional traction of 12 g for 
30-60 minutes and turbulence of the water column without leakage of fluid or slippage. 
The adhesive is nontoxic when in direct contact with human fetal membranes in an organ 
culture setting. A fetal membrane patch with multiphase adhesive complex
This chapter is reorganized from a pre-peer-reviewed version of the following article: 
Reprinted from Acta Biomateria., 8(6), L. K. Mann, R. Papanna, K. J. Moise, R. H. Byrd, 
E. J. Popek, S. Kaur, S. C. G. Tseng, and R. J. Stewart, Fetal Membrane Patch and 
Biomimetic Adhesive Coacervates as a Sealant for Fetoscopic Defects, 2160-2165, 
Copyright 2012, with permission from Elsevier.
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coacervates may help to seal the defect and prevent iatrogenic preterm premature rupture 
of the membranes.
3.2 Introduction
Iatrogenic preterm premature rupture of the membranes (iPPROM) after a fetal 
intervention procedure is a major complication that affects 10-47% of procedures [1-5]. 
iPPROM leads to an increased risk of preterm labor and worsens the perinatal mortality, 
undermining the true benefit of such interventions [6]. There are two possible 
explanations for the increased risk for iPPROM after invasive fetal procedures. One is the 
innate nonhealing nature of the fetal membranes, as demonstrated in both in vivo and in 
vitro studies [7,8]. The other is that separation of the amnion from the chorio-decidual 
layers that occurs during the introduction of instrumentation into the uterine cavity can 
cause a persistent parting of membranes with subsequent leakage of amniotic fluid [9]. 
There have been several attempts to study sealants at the site of the fetal membrane 
defect, both in vitro and in vivo [10-12]. However, there is no ideal in vitro model to 
simulate the relationship of the uterine wall, the fetal membranes, and the amniotic fluid 
environment. There is evidence to suggest that a decelluarized fetal membrane scaffold 
can promote cellular proliferation at the defect site [13]; however, no method to introduce 
a fetal membrane patch through a narrow operative cannula and deliver it to the site of 
the defect has ever been described. Additionally, after the patch has been deployed, the 
challenge of fixation to the membranes and the uterine wall remains due to the dynamic 
nature of the amniotic fluid and uterine musculature. An underwater adhesive that would 
fix a tissue scaffold to the edges of the defect in place for the remainder of the pregnancy 
would be an ideal solution to the problem iPPROM; however, no adhesive suitable for
this task is available.
Development of medical adhesives for the wet interior of the body is both 
chemically and biologically challenging. The adhesive must be delivered, bonded, and 
cured in the presence of moisture, must be nontoxic, and must not provoke a severe 
foreign body response. One approach to achieve underwater bonding is to study natural 
biological underwater adhesives, identify their key chemical features and copy that 
chemistry using nontoxic, biocompatible, and cost-effective synthetic polymers. 
Numerous aquatic organisms produce working underwater adhesives as part of their 
aquatic lifestyle to either position themselves in a suitable environment or to create a 
protective structure. The sandcastle worm, an intertidal marine polychaete 
(Phragmatopoma californica), produces a proteinaceous glue with which it joins together 
sand grains into a protective shell while fully submerged in seawater [14]. The proteins of 
the natural sandcastle glue are highly charged with opposite charges segregated into 
different proteins [15]. The polyacidic and polybasic nature of the glue proteins 
suggested complex coacervates—concentrated, phase-separated, associative polymer 
fluids—may be intermediates in natural bonding. Copying the side chain chemistry and 
molar ratios with synthetic poly(meth)acrylate copolymers resulted in adhesive complex 
coacervates that qualitatively replicated many of the features of the natural underwater 
adhesive [16]. Biodegradable versions [17] of the synthetic adhesive did not interfere 
with wound healing in a rat calvarial defect model [18]. Bond strength and other material 
properties were improved by introducing additional polymer networks into the adhesive 
coacervates [19].
In this study, we aimed to create an in vitro model to simulate the anatomical
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relationship of the fetal membranes, uterine wall, and surrounding amniotic fluid. Using 
such a model, we introduced an iatrogenic defect in a similar fashion to that used in 
clinical fetal interventions. Furthermore, we tested a technique to introduce a fetal 
membrane patch through a cannula to the site of a defect and test its sealing capacity and 
evaluated the use of multiphase adhesive coacervates to adhere the fetal membrane patch 
to the defect. In addition, we examined the potential tissue cytotoxicity of the adhesive 
coacervates in an in vitro culture system.
3.3 Materials and Methods
3.3.1 Creating an In Vitro Uterine Model
The Institutional Review Board of Baylor College of Medicine, Houston, TX 
(#H-26110), approved the collection of human fetal membranes for the study. We 
created an in vitro uterine model using a filleted poultry breast and human fetal 
membranes. A 100 ml polypro cylinder (VWR International, West Chester PA) was cut 
at the base and the cut end was lipped using heat. The cylinder was then mounted on a 
stand. Fresh human fetal membranes were obtained from term vaginal deliveries and 
were transferred to the laboratory in a balanced salt solution (BSS). The fetal membranes 
were cut into 6-cm diameter patches and secured to the lipped end of the cylinder with 
the amnion facing towards the inside of the cylinder. A poultry breast was filleted to 1­
cm thickness and pounded gently using a hammer to simulate the uterine wall 
musculature. A 6-cm diameter patch of poultry breast fillet was then wrapped over the 
fetal membranes on the cylinder and secured in place with a suture material. The column 
was filled using BSS.
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3.3.2 Creating an Iatrogenic Defect
A defect in the fetal membrane through the poultry breast and the fetal 
membranes was created using an 18-gauge needle, followed by a guide wire (Cook® 
Urological Inc; Bloomington, IN, USA). Subsequently, an 11 French Teflon cannula 
(Cook® Medical Inc, Bloomington, IN, USA) was introduced over the guide wire using 
Seldinger’s technique [20]. Then, the trocar was removed to leave the cannula in place. 
This entry method is identical to that used in most fetal intervention centers for fetal 
surgical procedures.
3.3.3 Technique to Introduce the Fetal Membrane Patch
Fetal membrane patches were supplied by Bio-Tissue, Inc. (Miami, FL) and 
processed in the same manner as described for human amniotic membrane currently used 
for ocular surface reconstruction [21]. Briefly, fetal membrane patches were placed on a 
nitrocellulose paper with the amniotic membrane facing up (for ease of handling). After 
being cut in a circular fashion to the desired size, they were lyophilized to reduce their 
thickness to facilitate their insertion into the cannula. Upon insertion, one edge of the 
membrane was removed from the paper and folded in half (Figure 3.1A). The center of 
the patch was lifted from the paper, and a 4-O Monocryl suture with a tapering needle 
(Ethicon Inc, San Angelo, TX) was passed through the center of the patch and a noose 
was tied (Figure 3.1B). The remainder of the patch was removed from the paper (Figure 
3.1C). The needle was removed from the suture and the distal end was passed through a 
9-French Teflon cannula while the self-check valve on the proximal end was removed 
using a knife. With gentle traction on the suture, the patch was retracted into the distal tip 
of the cannula (Figure 3.1D). The original trocar that was an integral part of the 9F
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Figure 3.1 In vitro model for uterine wall and a fetal membrane patch for the defect. (A) 
The lyophilized amnion-chorion is lifted off of the nitrocellulose paper; (B) a 4-0 
Monocryl suture is passed through the center of the patch; (C) a noose is tied to the fetal 
membrane patch to form a firm knot; (D) the free end of the suture is passed through a 9- 
French cannula, to align the knot inside the cannula (insert); (E) an in vivo uterine model 
with an 11-French cannula in place; (F) the 9-French cannula carrying the fetal 
membrane patch is inserted through the 11-French cannula, and the patch is introduced 
into the fluid using a blunt plunger; (G) both cannulas are withdrawn and the patch is 
aligned to the effect, followed by glue is applied around the patch; (H) the patch and the 
glue are in place.
cannula was modified to serve as a blunt introducer. This blunt introducer was advanced 
from the proximal end of the cannula to abut the patch. Once the 11-French cannula had 
been introduced through the base of the in vitro model, the 9-French cannula containing 
the membrane patch was introduced through it. The column was filled to a height of 10 
cm with BSS (Figure 3.1E). The patch was introduced into the fluid column advancing 
the blunt introducer. Once free within the fluid medium, the patch was allowed to swell 
for 2 minutes -  a timescale that had been established for maximum swelling based on 
prior experiments (Figure 3.1F). Both cannulas were then withdrawn while keeping the 
suture and the patch in place. The suture was then withdrawn gently to position the patch 
in the defect so that the amnion faced the fluid medium mimicking the amniotic fluid 
while the chorion faced the poultry breast mimicking the uterine wall (Figure 3.1G).
3.3.4 Optimization of the Membrane Patch Size for Sealing
Triplicates of lyophilized fetal membrane patches were created as mentioned 
above, with diameters ranging from 1 to 5 cm to determine the minimum size necessary 
to seal the iatrogenic defect in the above in vitro model. These were used to determine the 
sealing strength that could withstand the dislodgement of the plug. A 25 cm height of 
fluid in the column was chosen to mimic the average intrauterine amniotic fluid pressure 
of 18 mm Hg that we had observed in patients with excess amounts of amniotic fluid 
(data not shown). We additionally applied 12 g of traction to the plug and created 
turbulence in the fluid by shaking the column multiple times in all directions to mimic the 
in vivo fluid dynamics.
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3.3.5 Adhesive Complex Coacervate Formation
Polyethylene glycol diacrylate (PEG-dA, 760 Da, Aldrich) solutions were 
prepared in degassed, deionized water at the desired final concentration of 15 wt %. 
Poly(acrylamide-co-aminopropyl methacrylamide) (MW 288kDa, PDI 1.36) and poly (2- 
(methacryloyloxy)ethyl phosphate dopamine methacrylamide (MOEP-co-DMA, MW 
64kDa, PDI 2.8) were then dissolved in separate PEG-dA solutions at final 
concentrations of 5 wt %. The poly(MOEP-co-DMA)-PEG-dA solution also contained a
0.2 M ratio of Ca2+ to phosphate side chains and 1 wt % nanosilica fillers (10 nm, Aerosil 
R 7200). The copolymer solutions were separately adjusted to pH 7.4 ± 0.2 with 6 M 
NaOH. The poly(acrylamide-co-aminopropyl methacrylamide)-PEG-dA solution was 
added dropwise while stirring to the poly(MOEP-co-DMA)-PEG-dA solution to a molar 
ratio of 0.6 amine side chains to phosphate side chains. Within a few minutes the 
complex coacervate settled out. The clear supernatant was removed.
The adhesive PEG-dA and nanosilica-filled coacervates were cross-linked 
through the o-DHP side chains of the polyphosphate with the amine side chains of the 
polyamine and/or by polymerizing PEG-dA. o-DHP was oxidized to initiate cross­
linking by the addition of 1.0 M equivalents of NaIO4 relative to the o-DHP sidechains. 
The rate of oxidative cross-linking was slowed by forming a reversible 1:1 complex 
between NaIO4 and 1,2-O-Isopropylidene-D-glucofuranose (IPGF), as described 
previoulsy [22]. PEG-dA was polymerized by adding 3.5 mol % ammonium persulfate 
(APS) and 5.2 mol % N,N,N’,N’-tetramethylethylenediamine (TEMED) at the same time 
as NaIO4-IPGF.
Bond strengths of nanosilica-filled adhesive coacervates were tested in vitro on
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aluminum adherends, as described previously for multiphase conplex coacervates [19]. 
Briefly, NaIO4, APS, and TEMED were added to 20 ^l of coacervates, which was then 
applied to a wet 0.5 x 5 cm cleaned and polished Al adhered. A wet Al was placed on the 
first with a 14-20 mm overlap, secured with a stainless steel clip and cured by 
submergence in water for 20-24 h at 37 °C. Four to six specimens were prepared for each 
test condition. The load to failure of the bonds was determined on a material testing 
system (Instron) with a 500 N load cell at a crosshead speed of 0.2 mm min-1, while fully 
submerged in a temperature-controlled water bath at 37°C. In two separate experiments 
the loads were 524 ± 182 kPa (n = 5) and 698 ± 42 kPa (n = 3).
Bonding of the nanosilica-filled coacervates to aminiotic membranes was 
evaluated in vitro with fresh tissue cut into 1 cm x 6 cm patches. PEG-filled coacervates 
were prepared with and without nanosilica fillers. The coacervates (20^l) were applied to 
a 1 cm2 area, then adhered to a second overlapping patch. The overlapped areas were 
pressed together under a 20 g weight for 60 min, then manually peeled apart from one 
end with forceps. The relative bond strengths of the coacervates were graded on a scale of 
1-5, with 1 being the lowest bond strength and 5 being the highest. The nanosilica-filled 
adhesive coacervates formed substantially stronger bonds (4-5) with the amniotic 
membranes then the unfilled coacervates (1 -2).
3.3.6 Sealing of the Defect with Adhesive Coacervates
After we identified the size of the patch that could seal the defect but slipped out 
at a water column of < 10 cm height, we used that size for the remaining tests in 
conjunction with the glue. Four sets experiments were conducted with a different source
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of fetal membrane at each time. The application of the glue to the patch was timed. The 
sealing strength of the glue was examined by adding the BSS solution to the column to 25 
cm height and was further challenged by traction added to the patch with increments of 3 
g (maxiumum of 12 g). If the patch held a weight of 12 g, we observed the experiment for 
60 minutes (Figure 3.1H). Subsequently, the weights were removed and fluid turbulence 
was created by tilting the column in multiple directions for 5 min to evaluate for slippage 
of the glued plug.
3.3.7 In Vitro Cytotoxicity Test
The glue was evaluated for direct contact cytotoxicity on fresh term human fetal 
membranes obtained in a sterile fashion from three elective cesarean deliveries. These 
membranes were immediately transported to the laboratory in BSS with Pen-Strep 
(Gemini Bio-Products, West Sacramento, CA) sterilely cut into patches (2 x 2 cm) and 
placed in a six-well plate. In each test well, 200 |il of freshly prepared glue was applied 
over the amnion surface followed by the addition of 3 ml of Amniomax C-100 culture 
medium (Invitrogen Corporations, Carlsbad, CA). Membranes from control (n = 3) and 
test wells (n = 3) were harvested at 0, 24, and 48 h, fixed in 10% formalin, dehydration 
with 70% ethanol, embedded in paraffin, and sectioned for histological examination.
Slides were dewaxed, rehydrated, and digested in 0.02% trypsin solution and 
subjected to hematoxylin-eosin staining (H&E). TUNEL (terminal deoxynucleotidyle 
transferase dUTP nick end labelling) staining was also performed using ApopTag 
Peroxidase In Situ Apoptosis Detection Kit (Millipore, Billerica, MA). On the H&E 
slides, the overall morphological condition of the membranes was examined. In the 
TUNEL staining slides, the amniotic epithelial cells were counted in 10 high power fields
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or until reaching 500 cell count per slide. The cytotoxicity was calculated by determining 
the ratio of apoptotic cells to total number of amniotic epithelial cells.
3.3.8 Statistical Analyses
Statistical analysis was performed using Wilcoxon’s sum rank test for continuous 
variables and Fisher’s exact test for categorical variables. A p-value of <0.05 was 
considered to be significant.
3.4 Results and Discussion
3.4.1 In Vitro Uterine Model With a Fetal Membrane Patch and 
Its Sealing Capacity Without Adhesive Coacervates
The in-vitro uterine model and the iatrogenic defect were created successfully. 
We created four identical models, with a flow rate of 100 cc over 20 s. A patch size of < 
2 cm did not seal the defect from the beginning, and the patches slipped out with a 
column height of 10 cm or above. A patch size of 3 cm started to leak fluid with a column 
height of 5-10 cm and failed completely with a water column of 25 cm. A patch size of 4 
cm occluded the 11-French defect and was able to withstand a 25 cm column of fluid and
12 g of traction; when creating turbulence, two of the four patches were dislodged into 
the fluid column. A patch size of 5 cm did not fit into the 9-French cannula tip. 
Therefore, we chose a 3 cm lyophilized membrane for all subsequent adhesive coacervate 
experiments.
3.4.2 Sealing Test and Toxicity Testing With Adhesive Coacervates
As stated above, all four 3 cm patches began to exhibit leakage at a fluid column 
height between 5 and 10 cm without glue. The patches were dislodged spontaneously
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once the height of the fluid column reached 20 cm in two cases and dislodged 
immediately after applying 3 g of traction in the other two cases. In contrast, with 
additional glue, none of the cases demonstrated any leakage at a fluid height of 25 cm. 
Furthermore, no leakage was observed upon challenge with 12 g of traction for 30 
minutes in one experiment and 60 minutes in the other three (see Figure 3.2). The latter 
three cases also held the membrane patch in place even after turbulence created for 5 
minutes. They were then harvested and sectioned through the center to examine the 
junction between the membrane patch and the poultry breast wall. The glue was present 
in most of the junction between the poultry breast and the fetal membrane defect. In situ 
examination of the patch showed that the glue was spread 360° between the patch and the 
defect, including the fetal membrane edges and the muscular wall.
Histological examination revealed that the glue-added experimental group did not 
show any signs of cytotoxicity at any of the three time points compared to controls. At 
time 0, the control exhibited 2.2% of TUNEL-positive apoptotic cells. At 24 hours, the 
experimental group demonstrated 2% apoptotic cells while the control showed 4.2% 
apoptotic cells (p = 0.3). At 48 hours, the experimental group had 0.2% apoptotic cells 
while the control had 1.6 % apoptotic cells (p = 0.4).
3.4.3 Discussion
To investigate the potential efficacy of sealants for an iatrogenic defect created 
during a fetoscopic procedure, we need a model that simulates the fetal membrane and 
the uterine wall as well as the fluid dynamics of a pregnant uterus. Additionally, the 
model should be able to test a sealant’s capacity to occlude the defect and bind the fetal 
membrane to underlying layers to prevent leakage. In this regard, previously reported
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Figure 3.2 Fetal membrane patches sealing the defect with glue as an adhesive. The left 
image shows the experiment set-up for the in vitro uterine model. The illustration on the 
right shows the components of the model (dotted yellow line). (A) Fluid in a 100 cc 
column; (B) uterine wall simulation using fresh fetal membrane with the amnion facing 
the fluid column and the chicken breast on the outside; (C) traction of weight on the fetal 
membrane patch; -> fetal membrane patch in the defect with glue between the patch and 
the defect wall.
models have not managed to reproduce these in vivo conditions. For example, Reddy et 
al. [23] used a 2.5 cm diameter 20 mL syringe with a human fetal membrane attached to 
the bottom lip. After creating a 20-gauge needle defect in the fetal membrane, various 
sealants were tested for their abilities to occlude the leakage without describing the height 
of the fluid column. Their model cannot address the issue of chorioamnion separation. 
Furthermore, their defect size was smaller than the 2-3 mm diameter that typically occurs 
after fetoscopic procedures. Suzuki et al. [11] also attached fetal membranes to the 
bottom of cylinder and applied a gradual pressure up to 100 mm H2O using a water 
column. The defects created ranged from a pinhead hole to 5 and 10 mm slits. Because 
photocrosslinkable chitosan was applied as a sealant before adding fluid to the column, 
their model does not test the efficacy of the sealant in a fluid-filled environment. Bilic et 
al. [12] used a mechanical stretch device, the Cellerator, to study sealing of a 3.4 mm 
defect on a wet membrane with a “mussel inspired” PEG-based hydrogel. The efficacy of 
the glue to seal the defect was tested by stretching the membrane using the Cellerator. 
Their model also did not test the hydrogel in a fluid filled environment, and it remains 
unclear whether the mechanical stretching resembles the force caused by hydrostatic 
pressure. All three models did not consider binding of the fetal membrane to the 
underlying uterine wall, which is a likely solution to prevent iPPROM.
Our in vitro setting is a modified design of our previously published model [24], 
which was created to test the ability of a chicken ovomucin to seal a fetal membrane 
defect. The current model included a filleted chicken breast, simulating the uterine 
muscular layer, over the fetal membrane mimicking the natural anatomical relation. The 
aim of the model was to test the sealant’s capacity to occlude and hold the membranes to
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the muscular layer at the iatrogenic defect site. The model incorporates the biological and 
mechanical concerns leading to iPPROM. It is well known that the fetal membrane does 
not heal after an iatrogenic injury of greater than 2-3 mm in diameter, even up to 12 
weeks after the injury [7]. The presence of a chorioamnion separation detected by 
ultrasound in nearly 25-30% of patients after a fetoscopic procedure increases the risk 
for iPPROM by 3- to 4-fold [9]. Because the absence of chorioamnion separation reduces 
the risk for iPPROM, we speculate that the binding of the two layers of the fetal 
membranes, the amnion to the chorion, is a critical step in preventing the leakage of fluid. 
This is why we included the filleted poultry breast and used its smoother surface facing 
the chorion layer of the fetal membrane to simulate the in vivo relationship between the 
uterine wall and the fetal membranes. An iatrogenic defect in the muscle and fetal 
membranes was created using Seldinger’s technique, and the trocar was introduced in the 
same manner as it is introduced during clinical fetoscopic procedures. Our model 
therefore would be expected to produce similar stresses on tissue layers similar to those 
found in a clinical setting. Our method for introducing the patch through a narrower 
cannula is readily transferrable to a clinical application. The fetal membrane patch was 
designed in an “umbrella” shape, with an increasing thickness towards the amnioitc 
cavity. This helped to occlude the defect through a wedge effect by compressing the fetal 
membrane edges into the uterine wall to prevent chorioamnion separation. The pressure 
changes in a contractile uterus were simulated in our model by varying the height of the 
fluid column, while the traction challenge with fluid turbulence was added to simulate the 
complexity of uterine environment.
The fetal membrane patch used as a scaffold in our study was introduced with the
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chorion facing the defect site and the amnion facing the fluid environment. Previous 
studies have shown that an amniotic membrane scaffold fabricated into a plug promoted 
cellular proliferation at the site of a fetal membrane defect in vivo over a 7-day period 
[10-13]. Mallik et al. [13] used a surgical plug from a term decellularized fetal 
membrane for closure of fetal membrane defect in midgestation rabbits, resulting in 
integration of the scaffold into the fetal membrane and uterine wall in 71% of cases, as 
evidenced by cellular proliferation. A 4-mm diameter fetal membrane patch was found to 
seal the defect site without glue, but 50% of the patches were dislodged from the defect 
site with fluid turbulence. The lyophilization of the fresh human fetal membranes in our 
study reduced the bulkiness of the scaffold, which helped in the delivery through a 9- 
French cannula. After being introduced into the fluid environment, the lyophilized fetal 
membrane took approximately 2-3 minutes to regain its thickness and was secured in 
place with the suture, giving rise to an “umbrella” shape that enhanced its sealing 
capability. It remains to be determined whether the use of such a fetal membrane patch as 
described herein will promote better healing because the chorion facing the defect site 
might promote local scarring and the amnion facing the amniotic cavity might help 
reepithelialization.
We also noted that the adhesive coacervates helped seal the defect when the fetal 
membrane was 3 mm in diameter even under weight traction and fluid turbulence. The 
glue was injected between the membrane patch and the defect in the poultry breast 
muscle layers directly with a short applicator. In future testing, the glue could be applied 
with an introducer placed through the main cannula via a percutaneous approach. The 
glue spread 360° around the patch and the muscular wall—a desirable effect for
73
74
preventing chorioamnion separation. A volume of 200-300 |iL of glue was sufficient to 
seal the defect even in a water-filled environment. Future studies are needed to determine 
if the glue itself, or its degradative product, might be released into the amniotic cavity to 
generate any ill effect -  although it did not cause apoptosis in the amniotic epithelium. 
We chose to assess only the amniotic epithelial damage, as the amnion is considered the 
most important layer to maintain the integrity of the fetal membrane [10, 25].
3.5 Conclusion
Collectively, our in vitro model has demonstrated that a lyophilized fetal 
membrane patch effectively occluded a model of an iatrogenic fetal membrane defect in 
an aqueous environment. The patch was more effective when used in conjunction with a 
nanosilica-filled adhesive coacervate. Further studies in live animal models are needed to 
evaluate the efficacy and durability of this fetal membrane patch and the adhesive 
coacervates to assist in preventing iPPROM.
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CHAPTER 4
SYNTHESIS OF METHACRYLATED POLYPHOSPHATE 
AND POLYAMINE POLYMERS AND ADHESIVE 
COMPLEX COACERVATE FORMATION
4.1 Abstract
A stable complex coacervate adhesive was developed for long-term use in 
practical applications by modifying the chemistries of copolyelectrolytes. Two oppositely 
charged polymers, polyphosphate and polyamine, were synthesized with methacrylated 
group side chains as a new cross-linking system. Aqueous polymerization and grafting 
methods were carried out to improve biocompatibility of the final polymer. The 
polyamine polymer was synthesized by reversible addition-fragmentation chain transfer 
(RAFT) reaction to obtain a controlled molecular weight. Cross-linking kinetics were 
tailored by targeting specific methacrylation groups on each polymer. Complex 
coacervate range was explored by varying the polyamine to polyphosphate ratio for two 
different polyphosphate polymers. Coacervate concentration, flow behavior, and net 
charge varied depending on the polyamine to polyphosphate ratio. Nuclear magnetic 
resonance (NMR) was conducted on the varied polymer ratio coacervates to determine 
the actual charge on the adhesives. Viscosity measurements were made on the rheometer 
for flow behavior of the coacervates as well as a stability study of the adhesive for a 
month.
4.2 Introduction
The concept of complex coacervates was first introduced by Bungenberg de Jong 
in 1929 [1]. Complex coacervation occurs when two oppositely charged polyion solutions 
separate spontaneously upon mixing into two immiscible liquid phases. Both coacervate 
(dense) and a supernatant (dilute) liquid phase result, and both contain the two polyions 
[2]. Bungenberg explained that these phases were in thermodynamic equilibrium, and the 
formation was dependent on many factors like pH, temperature, concentrations, ionic 
strength, and molecular weight of the polyions. The term “complex coacervates” is 
defined as a system where two macropolyanions exist in a single solvent with formation 
of two phases. Following their work on gelatin/acacia coacervation, theoretical concepts 
on coacervation were being developed by Voorn-Overbeek [3-5] and Veis-Aranyi [6]. 
Voorn-Overbeek theory believed that a distributed electrostatic interaction allows 
coacervation to spontaneously exist, whereas Veis-Aranyi argued that entropy gain and 
rearrangement of oppositely charged polyions upon aggregation drives coacervation; 
these interactions can take hours to days to form coacervates. The contradiction in these 
theories and many more that followed occur because of the different type of coacervate 
systems that each studied. Over the years a lot of research has been underway to 
understand the coacervation phenomena especially due to it occurring naturally in 
biological environments [6]. The theories and its understanding were limited until the last 
decade, where improved techniques and characterization tools have aided in a better 
understanding [7-8].
Today ranges of examples of complex coacervates exist in nature in conjugation 
to synthetically derived coacervates used in applications [9-14]. Coacervates are found in
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applications of adhesives, coatings, biotechnology, and water purification systems [9]. 
These applications have played a key role behind the motivation to study the mechanism 
of coacervation and factors that impact it. Characterization techniques like dynamic light 
scattering (DLS), turbidity, rheology, and AFM have helped understand the mechanism 
behind these systems better [10-13]. Phase diagrams and viscoelastic behavior of 
coacervates to interfacial tension have all led to a better understanding of how 
coacervates are formed and aid in tailoring these properties to unlimited applications in 
the future.
There is a lot that can be learned from nature about the coacervate phenomena. 
Relative to our studies is the sandcastle worm underwater adhesive (Phragmatopoma 
californica, a marine polychaete) [15-17]. The sandcastle worm has a unique way of 
constructing composite mineralized shells that it lives in by binding sand grains and 
shells from aquatic environments. It does this by small amounts of underwater adhesive 
that it naturally secretes. This natural adhesive formed by the complex coacervation 
method is able to withstand strong forces in the ocean and tackle the adhesion of sand 
grains under aqueous conditions. These natural underwater adhesives are being studied in 
order to come up with solutions for synthetic adhesives [18-21]. The worm glue contains 
oppositely charged proteins, phosphates and amines, and divalent cations that form into a 
complex coacervate adhesive [16-17]. Research of the sandcastle worm led us to a 
biomimetic adhesive complex coacervate that mimicked the chemistries of the worm glue 
[18-21]. Copolyelectrolytes of oppositely charged phosphates and amines were 
synthesized, and when mixed under the set conditions a complex coacervate formed. The 
beauty of this adhesive lies in that it forms in water where the dense coacervate
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(adhesive) phase sinks to the bottom, it is immiscible in water, and adheres to wet 
surfaces where it stays in place underwater. The natural worm glue is chemically cross­
linked by 3,4-dihydroxy-L-phenylalanine (DOPA). The pH-triggered solidification 
occurs within seconds of its secretion from the worm. The synthetic version of this 
biomimetic was also cross-linked using DOPA residues on the synthetic polymeric chains 
[19-22].
Our current research is focused on developing a synthetic underwater adhesive 
targeted for medical applications, in particular soft tissue adhesion [22]. These 
biomimetic adhesives are advantageous because they can build on the natural phenomena 
and yet have highly tunable physical and mechanical properties [23]. With an application 
in mind, the biomimetic can be tailored to the needs of a commercial products. In the past 
we targeted high strength injectable multiphase adhesive coacervates for biomedical 
applications and attained our goals of a high strength deliverable adhesive through a fine 
cannula [21]. From the prospect of a commercial product, these adhesives need to be 
stored and be stable for extended periods of time in order to sustain its key properties 
until delivery to the site. The DOPA is well known to play a key role of cross-linking 
precursor [24-25], but its drawback lies in the oxidation of DOPA over time, leading to 
unstable and uncontrolled cross-linking of the adhesive taking place. Although many 
studies are underway to control the curing of DOPA mediated adhesives [26], tackling 
the problem of a stable adhesive for time periods of days is tricky. From an industrial 
standpoint, packaging and delivery of these adhesives play as much of a role as the 
product itself. These synthetic complex coacervates are unique, such that the polymeric 
backbones can be modified to meet the needs of the applications without losing the base
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concept of coacervation. This chapter is focused on modifying the synthetic polymeric 
backbones to incorporate a new cross-linking system that is more stable, controlled, and 
yet still meets the standards of a practical adhesive.
Putting vinyl groups on macromolecules is a well-known strategy for cross­
linking polymers. Both polymers in the synthetic complex coacervates were modified to 
incorporate reactive vinyl bonds. For the phosphate polymer, a carbon-carbon n-bond 
was incorporated into the structure via glycidyl methacrylate (GMA) [27-30]. Grafting 
with GMA in aqueous environments [30] is advantageous to our water-soluble polymers. 
The polymer gains more flexibility and longer chains from the GMA grafting. The amine 
polymer synthesized by aqueous RAFT (reversible addition-fragmentation chain transfer) 
polymerization [31-33] and incorporated the vinyl bond by reacting MAA (Methacrylic 
acid) and EDC (1-Ethyl-(3-dimethylaminopropyl) carbodiimide hydrocholoride).
In this chapter, we describe the method of synthesizing and methacrylating the 
two copolyelectrolytes used in complex coacervate systems. The coacervation system for 
a range of polymeric ratios and pHs were studied. The storage stability and coacervate 
adhesive properties are evaluated.
4.3 Materials and Methods
4.3.1 Materials
All reagents were used without further purification unless noted otherwise. 
Phosphorous oxychloride (POCl3, 98%), 2-hydroxyethylmethacrylate (HEMA, 97%), and 
triethylamine (99%) were purchased from VWR. The 4-Methoxy phenol was purchased 
from TCI. Methacrylic acid (MAA) was purchased from VWR and 2,2’- 
azobisisobutyronitrile (AIBN) from Polysciences. Inhibitor removing resin was
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purchased from Alfa Aesar. Glycidyl methacrylate(GMA) was purchased from Sigma 
Aldrich. Ultra filters Pellicon Ultracel Membranes (10 KDa) by Millipore were used. N- 
(3-Aminopropyl) Methacrylamide Hydrochloride and Acrylamide (Chemzymes, ultra 
pure) was purchased from Polysciences. 2,2’-Azobis(2-(2-imidazolin-2-yl) propane) 
dihydrochloride (VA-044) was purchased from Wako. EDC (1-Ethyl-(3- 
dimethylaminopropyl) carbodiimide hydrocholoride, anhydrous, 99.9%) was purchased 
from Chem-Impex Int. PEG-dA (Polyethylene glycol diacrylate, 540 Da was purchased 
from Sigma-Aldrich.
4.3.2 Polyphosphate Monomer Synthesis
The monomer 2-(methacryloyloxy)ethyl phosphate (MOEP) was synthesized by 
adding POCl3 (16.8g, 110 mmol) under flowing argon to a stirred solution of HEMA 
(12g, 92 mmol) in dry toluene (340 ml). The reaction mixture was cooled to 0°C, and 
triethylamine (39 ml, 276 mmol) was added slowly. The reaction proceeded at 0°C for 10 
minutes, then at room temperature for 2 hours. The white solid precipitate was recovered 
by filtration. Water (240 ml) was added to the cooled filtrate at 0°C and stirred at room 
temperature for 2 hours. The two layers were separated and the aqueous phase acidified, 
then extracted with THF: Ether (1:2, 8x110 ml). The organic phases were combined, 
dried over anyhydrous Na2SO4, and solvent evaporated to obtain the product as a pale 
yellow oil (67%, 12.2g). Inhibitor 4-methoxy phenol (1000 ppm) was added to the MOEP 
monomer and stored at -20°C. 1H NMR spectroscopy (400 MHz, D2O) d 1.7 (3H, s), 4.0 
(2H, m, POCH2), 4.2 (2H, m, POCH2CH2), 5.5 (1H,s) 6.0 (1H, s); 13C NMR (75 MHz, 
D2O) d 17.4, 64.2 (d, 2Jp o c  = 8.3 Hz), 64.4 (d, J p o c c  = 5.5Hz), 127.2, 135.6, 169.4; 31P 
NMR (120 MHz, D2O) d 0.97 (s).
4.3.3 Polyphosphate Copolyelectrolyte Synthesis
Poly(MOEP-co-MAA) was synthesized by free radical polymerization of MOEP 
and MAA. Inhibitor removing resin was used to remove the inhibitor from the MOEP 
and MAA before starting the polymerization. The comonomers were dissolved in 
methanol and purged with argon for 30 minutes. Recrystallized AIBN dissolved in 
methanol was purged separately. Reaction mixture was then brought to a temperature of 
55oC on oil bath before AIBN was added to initiate the polymerization. The reaction took 
place overnight for 16 hours and cooled to room temperature. The Poly(MOEP-co-MAA) 
was precipitated from methanol using acetone, and a gummy white polymer remained. 
The polymer was washed two more times with acetone to remove residual monomers. 
Two types of polyphosphate polymer were formed: 70 MOEP polymer starting out with 
85 mol% MOEP, and 40 MOEP polymer starting out with 55 mol% MOEP.
The Poly(MOEP-co-MAA) was chemically modified by GMA, modifying the 
MAA side chain. Varied amounts of methacrylated polymers were made depending on 
the degree of MAA in the copolymer. The precipitated polymer was dissolved (15 g) in 
100 mL of DI water. GMA (MAA mol%, 10X excess) was added to vigorously stirring 
polymer solution at room temperature overnight. The Poly(MOEP-GMA) was purified on 
ultrafilters with MWCO of 10 kDa. Purified polymer was stored as salt at pH 7.2, freeze- 
dried, and stored at -80 oC.
4.3.4 Polyamine Copolyelectrolyte Synthesis
Poly(acrylamide-co-aminopropyl methacrylamide) was synthesized by aqueous 
RAFT polymerization of acrylamide and N-(3-amino-propyl) methacrylamide
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hydrochloride. A water-soluble RAFT chain transfer agent (CTA, Figure 4.1)1 [34] was 
synthesized and used in this polymerization along with VA-044 as the initiator. The 
degree of polymerization (DP) was calculated to be the set MW/([M1]0 + [M2]0). The 
[CTA] was the total moles of monomer/DP. The CTA to initiator ratio was set to [CTA] 
to [I0] of 5:1. All reagents were dissolved in water (5 mL for every gram of reagent) and 
purged for 30 minutes in Argon. The polymerization took place at 60 oC overnight. The 
copolymers were purified by dialysis (MWCO 12 kDa) for 3 days and freeze dried. Two 
different polyamine polymers were polymerized: 75 mol % acrylamide with 25 mol % N- 
(3-amino-propyl) methacrylamide hydrochloride and 60 mol % acrylamide with 40 mol 
% N-(3-amino-propyl) methacrylamide hydrochloride with molecular weight of 30 KDa.
The Poly(acrylamide-co-aminopropyl methacrylamide) was chemically modified 
by MAA and EDC. The polymer was dissolved in DI H2O at a concentration of 30 
mg/ml. In the 25% amine content 5% amines were targeted to be methacrylated, which 
led to the ratio of 5% amines to MAA of 1:1, and MAA to EDC of 1 to 1.2. To get the 
targeted methacrylation, 5X excess MAA and EDC was added. To the dissolved polymer, 
MAA was added and pH rose to 5 using 6 M NaOH. EDC was then added to the reaction 
flask stirring at room temperature. The final pH was adjusted to pH 5.5 and stirred the 
reaction overnight at room temperature. The methacrylated amine polymer was then 
dialyzed for 3 days and freeze-dried and stored at -80 oC until use.
4.3.5 Copolymer Characterization
The molecular weight of the copolymers was determined by size exclusion 
chromatography (SEC, AKTA FPLC) in 20 mM phosphate and 500 mM NaCl (pH 7.4)




CTA Water Soluble MW = 374.54
Figure 4.1 Water-soluble RAFT chain transfer agent.
on column Superdex 210/300 GL (GE Healthcare). The columns were calibrated with 
polymethacrylate standards. The RAFT amine molecular weight was also measured using 
UV-vis (Perkin Elmer, Lambda Bio 20) absorption [35].
A Mercury Varian 400 MHz NMR spectrometer was used to characterize the 
polymers. 1H NMR (collection of 32 scans with a relaxation delay of 1.0 second) was 
able to quantify the amount of side chains on the polymers. Phosphorous-31 NMR was 
helpful in measuring the purity of the MOEP monomer. All the polymers were dissolved 
in Deuterium oxide (D2O) and run on NMR at a concentration of 10 mg/mL. Ninhydrin 
assay [26] was also used to compare the content of amine to NMR.
A Dynamic Titrator (Metrohm 808 Titrando) was used to carry out titrations of 
the monomer and polymers to determine the pKa’s.2 To titrate the phosphate, 0.005 M 
NaOH solution was used and for the amine, 0.15 M NaOH. Raw titration data were 
processed using a Gaussian moving average smoothing function in Matlab. PKa’s of the 
molecules were taken to be the pHs at the graphical inflection points as determined by a 
second derivative function in Matlab.
4.3.6 Complex Coacervate Formation
Methacrylated Poly(MOEP-co-MAA) and methacrylated Poly(acrylamide-co- 
aminopropyl methacrylamide) were dissolved separately in 150 mM aqueous NaCl 
solution at a concentration of 50 mg/mL polymeric solution. The copolymer solutions 
were adjusted to correct pH with NaOH, to pH 7.2 or pH 8.2. The poly(acrylamide-co- 
aminopropyl methacrylamide) solution was added dropwise while stirring to the 
poly(MOEP-co-MAA) solution to a set molar ratio of amine side chains to phosphate
2 Oscar V. Jasklowski carried out the titration of the monomer and polymers.
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side chains (A/P). In less than a minute a turbid coacervate settled out of solution. The 
coacervate was allowed to phase separate from the supernatant over a set time interval 
before being used for further analysis.
4.3.7 Complex Coacervate Characterization
Concentration of coacervates was measured on coacervates ripened for 24 hours 
at pH 7.2 for 70 MOEP and 40 MOEP polymers, and pH 8.2 for 70 MOEP polymers. 
Varied A/P ratios ranging from 0.1 to 1.3 and 0.1 to 2.5 were made to see the 
coacervation range. The coacervates formed within the range were separated into 
coacervate and supernatant phases. The coacervates and the supernatant were freeze- 
dried to measure the dry mass. The volume was measured from the images of the 
coacervate study. The concentration in mg per mL was measured at each ratio.
4.3.8 Complex Coacervate NMR Ratio Study
NMR study of the complex coacervates at various theoretical A/P ratios was 
conducted for 70 MOEP (pH 7.2 and pH 8.2) and 40 MOEP (pH 7.2) polymers. The 
coacervates were formed in 150 mM NaCl solution made in D2O and ripened for 24 
hours. The supernatant phase was removed and the coacervates were redissolved in 1M 
NaCl solution made in D2O. The dissolved coacervates in D2O salt were then run on 1H 
NMR. Using the NMR scans, the A/P ratio of the coacervates was determined.
4.3.9 Dynamic Rheology
Flow experiments were conducted on stress-controlled Rheometer (TA 
instrument, AR 2000 ex) using a 20 mm 4° cone geometry, gap 114 ^m, at 25°C with
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150 |iL coacervate samples. Coacervates were ripened for 24 hours. Viscosity of the 
uncross-linked coacervates at shear rate of 0.01(s-1) was measured (Peak hold, 24 data 
points per 2 minutes) at 25°C. For the Ripening study, coacervates were also formed and 
tested the same way after set time intervals. An average of three independently prepared 
coacervate samples were measured for each A/P ratio.
4.4 Results and Discussion
4.4.1 Polyphosphate Synthesis
The schematic of Poly(MOEP-co-MAA) polymerization and methacrylation is 
shown in Figure 4.2 A. Polyphosphate polymer was polymerized with MOEP and MAA 
(In 40 MOEP, polymer hydroxyethylmethacrylate (HEMA) was also polymerized). The 
HEMA results as a byproduct in the reaction by cleavage of the phosphate group from the 
MOEP side chain. The chemical modification of the Poly(MOEP-co-MAA) in the second 
step resulted in grafting of GMA onto the MAA side chain, where 10X excess GMA 
results in a high degree of conversion. This ring opening pathway isomer results due to 
the grafting taking place at very acidic conditions. Both isomers are possible but this one 
is more prevalent. Targeted methacrylation of this polymer resulted from controlling the 
amount of MAA in the polymerization step.
4.4.2 Polyamine Synthesis
Aqueous RAFT polymerization of Poly (acrylamide-co-aminopropyl 
methacrylamide) and methacrylation are shown in Figure 4.2 B. A set molecular weight 
polymer with a targeted amount of side chains was achieved. The synthesis was carried 
out in H2O using water-soluble RAFT agents. To achieve a controlled polymerized
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Figure 4.2 A) Schematic of Methacrylated Poly(MOEP-co-MAA) polymer, and B) 
schematic of Methacrylated RAFT Poly (acrylamide-co-aminopropyl methacrylamide).
polyamine polymer, a kinetics study of the reaction was carried out. At set time intervals, 
aliquots of the reaction were taken out and quenched and tested on the SEC FPLC. The 
data show the reaction goes to completion in 2 hours and plateaus. The FPLC curves 
generated from each data set showed that molecular weight peak getting narrower over 
time, which shows a very controlled synthesis. Within a few hours the targeted molecular 
weight with a sharp narrow peak with low PDI is achieved. Most of the monomer is 
consumed at that point, and the reaction is done.
4.4.3 Copolymer Characterization
SEC measured the molecular weights of both copolymers in this study. To control 
the molecular weight of Poly(MOEP-co-MAA) polymer, led by free radical 
polymerization method, a controlled initiator and temperature study was carried out. The 
AIBN initiator concentration ranged from 1.8-5 mol% of the total monomer, and 
temperature was varied from 50°C to 60°C. To get the targeted range of MW for the 
polyphosphate polymer, 4.5 mol% AIBN of the monomers and 55°C were used. The 
Poly(MOEP-co-MAA) polymer used in this study had the MW of 70.3 KDa and PDI of 
1.37 for 70 MOEP polymer, and MW of 85.1 KDa and PDI 1.3 for 40 MOEP polymer. 
For the Poly (acrylamide-co-aminopropyl methacrylamide), targeted MW polymers by 
aqueous RAFT polymerization were synthesized, a 40 KDa and a 100 KDa. The 
polymers used in this study measured to have MW of 40.1 KDa and PDI of 1.1, and the 
second one of MW 96.1 and PDI of 1.0. The molecular weights of the RAFT polyamine 
were also confirmed by UV/Vis method and reported to be in agreement with the FPLC 
data.
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The methacrylation and the amount of each group on the polymer side chains 
were verified by NMR spectroscopy. By NMR methacrylated Poly(MOEP-co-MAA) 
used in this study contained 73.9 mol% MOEP, 8.1 mol% HEMA, and 18.0 mol% 
grafted GMA side chains (Figure 4.3A). The Methacrylated Poly (acrylamide-co- 
aminopropyl methacrylamide) contained 77.2 mol% Acrylamide, 16.5 mol% 
Aminopropyl Methacrylamide, and 6.3 mol% Grafted Amine (Figure 4.3B). Targeted 
amount of methacrylation for each polymer was achieved with precise control on the 
synthesis. In the polyphosphate polymer all of the MAA had to be converted to the 
methacrylated group; therefore, 10 X excess GMA had to be added to get 100% 
conversion. For the polyamine polymer, however, only part of the aminopropyl side 
chain was being converted to the methacrylated side chain, so a very controlled grafting 
reaction had to take place. Figure 4.3C shows the controlled grafting reaction by addition 
of EDC and MAA to the aminopropyl in the RAFT amine polymer, starting from the 
bottom 0, 0.5, 1, 2.5, 5, and 10 X excess reagents. So to target 5% of the amines of the 
total 25% of the amine groups, 5X excess MAA and EDC were added. A set amount of 
grafting of each polymer is the key in getting the mechanical properties needed in the 
final cross-linked complex coacervates. The content of the amine in the Poly 
(acrylamide-co-aminopropyl methacrylamide) polymer was also verified by ninhydrin 
Assay, which confirmed similar content.
The titration data of methacrylated Poly (acrylamide-co-aminopropyl 
methacrylamide) and its monomer aminopropyl methacrylamide, and methacrylated 
Poly(MOEP-co-MAA) polymer and its MOEP monomer, are overlaid together on the 
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Figure 4.3 H1 NMR Spectra: A) Methacrylated Poly(MOEP-co-MAA) polymer, B) 
Methacrylated Poly (acrylamide-co-aminopropyl methacrylamide), C) Controlled 






Figure 4.4 Titration curves of Methacrylated Poly (acrylamide-co-aminopropyl 
methacrylamide)[pKa 10.13] and its monomer Aminopropyl Methacrylamide [pKa 
10.17], and Methacrylated Poly(MOEP-co-MAA) polymer [pKa 7.28], and its MOEP 
monomer [pKa 6.46].
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polymers demonstrate improved buffering capacity as compared to monomers. The 
amine polymer demonstrates a lowered pKa as compared to the monomer, as elevated 
positive charge density facilitates deprotonation with increasing pH. The phosphate 
polymer features an elevated second pKa as a result of high negative charge density on 
the phosphate polymer inhibiting further deprotonation. The disparity between 
monomer/polymer pKa differences between amines and phosphates can be attributed to 
the high charge density on phosphate polymers as compared to low charge density on 
amine polymer. Between pH's of 8 and 9 there is minimal change in protonation state for 
either polymer, providing a functional pH range in which coacervate properties that 
depend on interactions between the polyelectrolytes are consistent.
4.4.4 Complex Coacervate Ratio Study
The complex coacervate adhesive formation with methacrylated polymers was 
extensively studied. The coacervates were formed for two different polymers, 70 MOEP 
and 40 MOEP, over a range of A/P ratios and two different pHs (Figure 4.5). With 
increasing A/P ratio, the solution went from clear to the coacervate phase to cloudy and 
then clear again. At pH 8.2, there was an extra ratio that the coacervate formed compared 
to pH 7.2 (Figure 4.5A and 4.5B). In 40 MOEP polymer coacervate a higher range of 
coacervation occurred than 70 MOEP, from A/P ratio 0.7 to 2.2 (Figure 4.5C). The 
coacervates formed had different appearance and flow behavior at the varied A/P ratios. 
With increasing ratio the coacervates became apparently more viscous as shown in Figure 
4.5D.
To characterize these coacervates further NMR characterization study was 
conducted as listed in Table 4.1. The NMR A/P ratio comes from direct correlation of
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Figure 4.5 Complex coacervate range of methacrylated polymers with varying A/P ratios 
after 24 hour ripening for A) 70 MOEP polymer from 0.1 to 1.3 at pH 7.2, B) 70 MOEP 
polymer from 0.1 to 1.3 at pH 8.2, C) 40 MOEP polymer from 0.1 to 2.5 at pH 7.2, and 
D) flow behavior of 70 MOEP coacervate at pH 8.2.
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Table 4.1 Coacervate ratio study with theoretical ratio, NMR ratio, net charge ratio, 
concentration, and viscosity [at shear rate of 0.01 (s-1)] at pH 7.2 for 70 and 40 MOEP 
polymers, and pH 8.2 for 70 MOEP polymers, after 24 hour of ripening
70 MOEP, pH 7.2
A/P A/P Net
Ratio Ratio Charge Concentration nTheoretical NMR Ratio (mg/mL) (Pa- s)
0.25 0.51 -0.99 103.9 6 i+ 4
0.40 0.55 -0.95 140.0 1.9±0.9
0.55 0.66 -0.84 139.0 4. 6 i+ 8
0.70 0.75 -0.75 158.7 10.5±1.2
0.85 0.95 -0.55 130.2 13.6±2.4
70 MOEP, pH 8.2
A/P A/P Net
Ratio Ratio Charge Concentration nTheoretical NMR Ratio (mg/mL) (Pa- s)
0.25 0.50 -1.50 104.0 3. 3 i+ 7
0.40 0.57 -1.43 126.9 4. 7 1 5
0.55 0.70 -1.30 132.7 7. 4 i+ 8
0.70 0.82 -1.18 165.3 12.4±2.0
0.85 0.96 -1.04 150.4 30.7±3.7
1.00 1.14 -0.86 98.0 51.1±7.3












0.70 1.22 -0.28 171.8 2.6±0.4
1.00 1.48 -0.02 180.2 3.7±0.5
1.30 1.79 +0.29 203.7 8. 4 1+ 5
1.60 2.04 +0.54 210.4 11.5±1.8
1.90 2.47 +0.97 209.1 8. 2 i+ 9
2.20 2.62 +1.12 132.6 2. 8 i+ 5
amines to phosphates on the NMR spectra of the coacervates. The H1 NMR peak of the 
coacervate compared polyamine peak at 3ppm (Figure 4.3B) to polyphosphate peak at 
4ppm (Figure 4.3A), and the NMR ratio was calculated. The coacervate forms with the 
addition of polyamine solution to the polyphosphate solution, under vortex, despite the 
theoretical A/P ratio being set. The coacervate has a natural way of forming into a 
polyelectrolyte charge ratio and taking that into the coacervate and leaving the excess 
polyelectrolyte into the supernatant. In both polymers and the two pHs, the NMR ratio is 
higher than the theoretical.
The net charge ratio was also calculated based on the NMR ratio data listed in 
Table 4.1. Each phosphate group has a negative 1.5 charge at pH 7.2 and negative 2 
charge at pH 8.2. Taking the A/P NMR ratio into account gives us the net charge ratio of 
these coacervates. Coacervates made from 70 MOEP polymers at the two pHs are 
negatively charged. At pH 8.2 they are more negatively charged than pH 7.2. And after 
getting to the lower negative ratio, the coacervates do not form and instead a milky 
solution results. However, for 40 MOEP, polymer coacervates at pH 7.2 negative and 
positive charged coacervates result. The concentration (mg/mL) of these coacervates was 
measured using the dry mass from coacervates and volume from the images, after 24 hrs 
of ripening. The quantitative values show an increasing density with increasing A/P ratio, 
which then decreases at the end of the A/P range coacervates. Both the concentration and 
net charge of the coacervates show that these charged polyelectrolytes have their own 
way of formation and balance of charges for it to take place.
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4.4.5 Rheology: Viscoelastic Properties of Complex Coacervates
The flow behavior of these coacervates was quantified on the Rheometer by 
measuring the viscosity at very low shear rates, an average of 20 data points for 2 
minutes. The coacervates were allowed to settle naturally over a 24-hour period. The 
viscosity results shown in Table 4.1 show increasing viscosity over increasing amine to 
phosphate ratios for both pHs and polymers. These data correlate well with Figure 4.5 D, 
showing increasing viscosity coacervate with increasing A/P ratio.
Ripening over a longer period of time was also conducted at the two different 
pH’s for the lower, middle, and upper range A/P ratio (Figure 4.6). Viscosity 
measurements were measured the same way at low shear rates. The results showed very 
stable coacervates over a period of a month. With a very minimal increase in viscosity 
over time, these coacervates can be stored over a month.
4.4.6 Discussion
We can learn and understand many things from the coacervation phenomena and 
apply its science to many current day solutions. Especially when they exist in nature, like 
in the case of sandcastle worm secreting its underwater adhesive to bind sand grains. 
Biomimetics are very unique because they build on nature’s concepts. The synthetic can 
be designed with tunable properties to the desired application. Our synthetic complex 
coacervate adhesive inspired by nature was developed for adhesion and repair of the soft 
tissue. The adhesive must meet the following criteria: adhere to soft tissue with sufficient 
strength; be biocompatiable, nontoxic, and deliverable; and have adhesive stability, 
dimensional stability under biological conditions, and controlled curing kinetics. In the 







Figure 4.6 Viscosity at shear rate 0.01 (s-1) over ripening time course at various Amine to 
Phosphate Ratio’s at A) pH 7.2, B) pH 8.2.
with sufficient bond strengths [19-22, 26]. But adhesive stability with a DOPA-mediated 
precursor has always been challenging.
To overcome the challenges of a stable complex coacervate adhesive over 
extended periods of time, new crosslinking chemistries were introduced into the 
polymers. The concept of methacrylating polymers is not new, but the incorporation of 
the vinyl group into the phosphate and amine polymer backbone was tricky. Through trial 
and error, we developed the final method of having controlled, characterized, and stable 
polymers. The synthesis and grafting of poly(MOEP-co-MAA) was highly efficient in 
getting the right amount of side chains and vinyl groups on the polymeric backbone. The 
molecular weight of the polymer was controlled by the initiator concentration and 
temperature. Aqueous RAFT polymerization of poly(acrylamide-co-aminopropyl 
methacrylamide) improves the narrow window of targeted molecular weight and side 
chains. The narrow molecular weight distribution is confirmed by the SEC and UV/Vis 
data. NMR, titration data, and the Ninhydrin Assay confirm the content of the amine in 
this polymer. The methacrylated groups are well distinguished on both polymers in H1 
NMR.
The modified polymers formed stable complex coacervates at different pH’s and 
polymers at varied amine to phosphate ratios. The coacervation ratio study was insightful 
in predicting the A/P to use for a set viscosity. The rheological flow behavior of these 
coacervates confirmed the value by quantifying the viscosity measurements (Table 4.1). 
The range of viscosities open up the complex coacervate adhesive to a wide variety of 
applications to be used by picking the set ratio of the polymer or pH range. In designing 
the adhesive for a set application, this is a unique property. The ripening/stability of these
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coacervates show a very stable coacervate over a period of a month. This again confirms 
that storage stability of these polymers and coacervate adhesives.
4.5 Conclusion
Methacrylated polyphosphate and methacrylated polyamine polymers were 
synthesized for stable complex coacervate formation. An aqueous grafting of the 
poly(MOEP-co-MAA) polymer resulted in a clean methacrylated polymer. RAFT 
polymerization of poly(acrylamide-co-aminopropyl methacrylamide) resulted in a 
controlled molecular weight polyamine polymer. Targeted methacrylation on each 
polymer was achieved. The coacervation ratio study gave us a range of properties to 
choose from for its application. The coacervates formed with this new crosslinking 
system are more stable for long term use.
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CHAPTER 5
METHACRYLATED POLYMERS COMPLEX 
COACERVATE ADHESIVE FOR SEALING 
FETAL DEFECTS IN TWIN-TO-TWIN 
TRANSFUSION SYNDROME
5.1 Introduction
According to the USA National Center for Health Statistics, in 2005 there were 
4,500 cases of twin-to-twin transfusion syndrome (TTTS) involving 9,000 babies [1]. 
TTTS is a birth defect in which two fetuses get an unequal or unbalanced blood supply 
from the mother, leading to asymmetrical fetal growth and fetal mortality. It is a 
progressive disease, which when left untreated can lead to fatal consequences for the 
mother and the babies. This condition occurs in monozygotic (MZ) twins where the twins 
share a common placenta with connecting blood vessels, giving excess blood supply to 
one baby and too little to the other. An effective treatment used in TTTS is fetoscopic 
laser photocoagulation, in which the laser is used to photocoagulate the vessels crossing 
the intertwin membrane. This method not only stops the blood supply between the twins, 
but also stops the transfer of any vasoactive mediators [2]. Despite the improved outcome 
of the laser photocoagulation treatment of TTTS, there are major postintervention 
challenges. Iatrogenic preterm premature rupture of the fetal membrane (iPPROM) is the 
major threat. In the TTTS treatment an 8 mm diameter fetoscope punctures the amniotic
fetal membrane, and the laser optic is inserted through the scope. The fetal membrane 
does not naturally heal [3], leading to amniotic fluid leakage. The iPPPROM is a 
common drawback of all fetoscopic procedures, limiting the use of these procedures in 
diagnosis and treatment. Adhesives that can plug up these fetal defects after fetoscopic 
procedures have shown promising results, but the adhesion in aqueous environments 
along with cytotoxicity poses major challenges [4].
Aquatic organisms like the sandcastle worm, Phragmatopoma californica, a 
marine polychaete, can teach us immensely about underwater adhesion [5-7]. This worm 
living along the coastlines secretes glue out of its building organ, which binds sandgrains 
and shells from the ocean, and builds a shell that it lives in. Despite all temperature, 
pressures, and salt changes in the ocean, this mineralized shell does not fall apart. The 
sandcastle worm has evolved its solutions over the years to tackle the underwater 
adhesion problem, where so many synthetic glues have fail. This animal is the inspiration 
behind our synthetic analog to make this bioadhesive [8-11]. The worm glue contains 
many components, but of interest to us are the oppositely charged proteins, mainly 
phosphates and amines. These proteins led us to our biomimetic adhesive formed by the 
method of complex coacervation.
Complex coacervation is a fluid-fluid phase separation of two oppositely charged 
copolyelectrolytes in aqueous solution. The dense phase, also known as coacervate, 
settles to the bottom and the dilute phase, known as supernatant, remains on top [12]. 
Both phases coexist in equilibrium and are dependent on many factors like pH, 
temperature, concentration, ionic strength, and molecular weight of the polyelectrolytes. 
For the biomimetic adhesive, oppositely charged phosphate and amine polymers were
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synthesized, and when mixed under the set conditions, a complex coacervate resulted. 
Preliminary studies on sealing fetal defects have shown that our synthetic analog adheres 
well to fetal tissue and is able to hold the amniotic membrane plug in place [13]. This 
synthetic complex coacervate adhesive is chemically cross-linked through 3,4-dihydroxy- 
L-phenylalanine (DOPA), which makes it unstable and difficult to control the 
crosslinking. This limits the use of DOPA-based analog adhesives in practical 
applications.
This chapter is focused on developing a synthetic complex coacervate adhesive 
based on the methacrylated copolyelectrolytes (shown in Chapter 4), which are more 
stable to use, for TTTS repair. Vinyl groups are put on the polymers, consisting of the 
oppositely charged phosphates and amines, as a better crosslinking system. A chemically 
cross-linked adhesive system is created. This adhesive in conjunction with the fetal 
membrane patch will be used to plug the punctured fetal membranes in pig animal 
studies. Sodium (meta) periodate (NaIO4) is the crosslinker used to crosslink the 
methacryalted complex coacervate adhesive. The crosslinking kinetics of the adhesive 
system is optimized to practical clinical timing. The adhesion properties of this 
chemically crosslinked glue are tested on the lap shear test. The cytotoxicity of the glue is 
tested to make sure it is not toxic. Sterile complex coacervate adhesive packets are 
prepared for the animal surgeries. In this chapter we have prepared the sterile adhesive 
packets that are successfully being used in current animal studies, where the initial results 
are showing promising results.
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5.2 Materials and Methods
5.2.1 Materials
All reagents were used without further purification unless noted otherwise. 
Inhibitor removing resin was purchased from Alfa Aesar. PEG-dA (Polyethylene glycol 
diacrylate, 540 Da), PEG-dMA (Polyethylene glycol dimethacrylate, 750 KDa), Sodium 
(meta) periodate (>99.0%), and basic aluminum oxide were purchased from Sigma- 
Aldrich.
5.2.2 Purification of PEG Monomers
The inhibitor in PEG-dA and PEG-dMA monomer had to be removed. The liquid 
monomers were passed through an activated basic aluminum oxide column, removing the 
inhibitor hydroquinone monomethyl ether (MEHQ).
5.2.3 Complex Coacervate Adhesive Formation
Methacrylated Poly(MOEP-co-MAA) (as described in Chapter 4) and 
methacrylated Poly(acrylamide-co-aminopropyl methacrylamide) (as described in 
Chapter 4), were dissolved separately in aqueous 150mM NaCl solution at a 
concentration of 50 mg/mL. The copolymer solutions were adjusted to the correct pH of 
7.2±0.2, with NaOH. The poly(acrylamide-co-aminopropyl methacrylamide) solution 
was added dropwise to the poly(MOEP-co-MAA) solution under vortex. The molar ratio 
of amine sidechains to phosphate sidechains (A/P) was fixed. For 40 MOEP polymer, a 
coacervate A/P ratio of 1 was used and for 70 MOEP polymer, a coacervate A/P ratio of
0.65 was used. In less than a minute, turbid coacervate settled out of solution. The 
coacervates were allowed to phase separate from the supernatant for 24 hrs before being
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used for further analysis. The multiphase complex coacervate incorporating PEG-dA was 
formed the same way with the additional step of dissolving the desired concentration 
(0-15 wt%) of PEG-dA into dissolved methacrylated Poly(MOEP-co-MAA) polymer, 
taking into account a fixed volume in the end.
5.2.4 Polymeric Solution for Crosslinking Kinetics on the Rheometer
Methacrylated Poly(MOEP-co-MAA) and methacrylated Poly(acrylamide-co- 
aminopropyl methacrylamide) were dissolved separately in aqueous 150mM NaCl 
solution at a concentration of 200 mg/mL. The pH of each solution was adjusted to a set 
pH.
5.2.5 Dynamic Rheology
The gelation kinetics of the adhesive complex coacervate was conducted on a 
stress-controlled Rheometer (TA instrument, AR 2000 ex) using a 20 mm, 4° cone 
geometry, gap 114 ^m, at 37°C with 150 |iL coacervate samples. Gelation kinetics of 
crosslinked coacervates were measured using the Oscillatory time sweep method on the 
Rheometer. The change in elastic (G') and viscous (G'') moduli over time was measured 
at a constant frequency of 1 Hz and constant strain of 1%. The coacervates were 
crosslinked through vinyl groups on both polymers with NaIO4 in varied mM 
concentrations (10-50 mM). The 10 ^l of NaIO4 stock solution was mixed into 200 ^l 
coacervate. The mixed coacervate was loaded onto the rheometer, and the method 
initiated. The gelation kinetics of polymeric solutions was also measured the same way, 
by mixing 10 ^l of NaIO4 stock solution with 200 ^l polymeric solutions.
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5.2.6 Mechanical Testing
The adhesion properties of complex coacervates were tested using a lap shear test 
on a material testing system (Instron). Aluminum substrates of dimensions 0.5 x 5 cm 
were used in the lap shear method. The substrates were cleaned using a standard method: 
polished on 600 grit sand paper, washed twice in a ultrasonic methanol bath, washed 10 
min in sulfuric acid bath, and finally washed in water. To bond the aluminum substrates, 
the complex coacervate were mixed in with 5% dilution of 20 mM NaIO4. About 20 ^l of 
coacervate/mixed with NaIO4 were applied to wet Al adherend. The second wet Al were 
placed on the first with a 14-20 mm overlap. The two substrates at the overlap were 
secured with a stainless steel clip. The samples were than placed in a water bath, at 37°C, 
for 2 hours until testing. The shear strength of the bonds were determined on a material 
testing system (Instron) with a 100 N load cell, crosshead speed 10 mm min-1. Once the 
substrates failed, the overlap area was taken into to account as well as the failed load to 
calculate the bond strength. For each condition four specimens/measurements were 
tested.
5.2.7 Cytotoxicity1
Mouse osteoblasts (MC3T3-E1 subclone 4, ATCC CRL-2593, Manassas, VA, 
USA) were used as the cell line. The cells were maintained in essential medium 
supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 ^g/ml 
streptomycine in a humidified 5% CO2 and 95% air balanced incubator at 37oC. The 
medium was changed every other day. The direct contact cell culture test was used to 
evaluate cytotoxicity of the complex coacervate. To 32 pil, adhesive uncrosslinked or
1Hui Shao carried out the cytotoxicity assay.
112
crosslinked, and 256 ^l medium was added into a culture well plate and incubated 37°C 
for 24 hours. In another plate MC3T3-E1 osteoblast cells were plated, with density of 
100, 000 cells/well in the growth medium, incubated at 37°C for 48 hours. After 48 hours 
the medium from the MC3T3-E1 cells was removed, and from the adhesive plate the 
medium was added into the cell plate. After 48 hours the cell number of MC3T3 on the 
adhesive was determined using the MTT assay. MTT was dissolved in sterile PBS (5 
mg/ml). 100 ^l of the MTT stock solution was added to each well and incubated at 37oC 
for 4 hours. After incubation, 1000 ^l of the SDS-HCl solution (0.1 g/ml in 0.01 M HCl) 
were added to each well and mix thoroughly using pipette to extract the formazan crystals. 
The plate was then incubated at 37oC for another 4 hours in a humidified chamber. After 
incubation, the extract of each sample was transferred to the 96-well plate and the 
absorbance intensities were measured at 570 nm using a microplate reader.
5.2.8 Sterilization of Coacervates
Sterile coacervate adhesive packets were prepared for the animal studies. In a 
sterile hood, all aqueous polymeric solutions were filtered through a 0.22 ^m sterile 
filter. The sterile poly(acrylamide-co-aminopropyl methacrylamide) solution was added 
dropwise to the sterile poly(MOEP-co-MAA) solution under vortex. The coacervates 
were ripened for 24 hours. The adhesives were packed in 1 mL syringes with a tight seal 
cap, (Qosina, Inc), sterilized by ethylene oxide sterilization (40°C). The loaded sterile 
syringe was then put into a sterile 50 mL centrifuge tube to be kept in a sterile packet till 
surgery. The chemical initiator, NaIO4, was loaded into the second syringe the same way. 
The NaIO4 stock solution was filtered through the 0.22 ^m filter to make it sterile.
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5.2.9 Complex Coacervate Adhesive Packets used in Animal Studies
The adhesive and the initiator were packaged separately in two different leur-lock 
sterile syringes. At the animal study surgery room, a sterile mixing nozzle is connected to 
the two syringes by pushing all of the material of one syringe into the other, and vice 
versa, mixing 5-10 times in the initiator with the adhesive. Once mixed, all of the 
adhesive/initiators were pushed into one syringe, the empty syringe was removed, and the 
mixing nozzle was removed, and by attaching a cannula to the leur-lock, syringe adhesive 
can be applied to the test site. The adhesive has to be applied within a minute of mixing.
5.3 Results and Discussion
5.3.1 Rheology
The crosslinking kinetics of complex coacervate adhesive was measured on the 
Rheometer. Varied polymer composition coacervates of polyphosphate and polyamine 
polymers (Figure 5.1) were compared. It is important for this newly crosslinked system to 
crosslink fast enough for the physician so that they do not have to wait hours for the glue 
to set and yet not set too fast that it turns into a solid gel before applying to the site. The 
crosslinking time can be optimized on the rheometer using dynamic oscillatory rheology 
by time sweep method. For this application we want the adhesive to fully set between 5 
to 10 minutes. Sodium (meta) periodate was used as the crosslinker to crosslink the 
methacrylated complex coacervate adhesive. The coacervates were formed at the 
biological pH of 7.2±0.2 and temperature of 37°C. The elastic modulus of complex 
coacervate, made of 40 mol% MOEP and 1% methacylated polyphosphate with 5% 
methacrylated polyamine, was optimized for NaIO4 concentration as shown in Figure 5.2. 
The coacervates initially crosslinked in less than a minute for all concentrations, not
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Figure 5.1 The varied polymers used in this study: polyphosphates (Methacrylated 
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Figure 5.2 Elastic modulus of complex coacervates made of 40 MOEP-1% 
methacrylation on the polyphosphate polymer and 5% methacrylation on the polyamine 
polymer at pH 7.2, with varied NaIO4 concentrations at 37°C: A) Time sweep curve, and 
B) showing elastic modulus vs. NaIO4 concentration.
shown in the figure, where the G’ crosses over the G”, also known as the reference point 
where the adhesive starts to go from a viscous fluid to crosslinked elastic network [14]. 
The G’ plateaus eventually over time for all the NaIO4 concentrations as shown in the 
time sweep curve in Figure 5.2A. The elastic modulus for the 40 MOEP-1% 
methacrylated coacervate reached a maxiumum around 10 KPa, optimizing the NaIO4 
concentration between 20 and 30 mM (Figure 5.2B). The elastic modulus plateau was 
also evaluated for varied methacrylated polymers within the coacervate, as shown in 
Figure 5.3. As the methacrylation on the polyphosphate increased within the coacervate, 
the elastic modulus increased. The difference between the nonmethacrylated polyamine 
and the methacrylated polyamine was very large. This result is insightful because the 
methacrylation on both polymers is necessary to maximize the modulus. These data also 
show us the range of properties of elastic modulus that we can choose from for our 
application of TTTS. The correct modulus for this soft tissue adhesive application, 
however, is difficult to pinpoint. We know that the modulus should be somewhere 
comparable to that of the fetal tissue membrane. We do not want the modulus of the 
adhesive to be too stiff where it hardens into a stiff gel, nor do we want a mushy gel that 
is only partially crosslinked. We want something in between that adheres well to the fetal 
tissue without a modulus mismatch between the interfaces of the soft tissue. We observed 
the effect of modulus upon the geometry on the rheometer, as it is being lifted off as the 
complex coacervate adhesives have reached a plateau (Figure 5.4A). This sample shown 
in the image is the 70 M0EP-20% methacrylated polyphosphate and 5% methacrylated 
polyamine coacervate crosslinked with 10 mM NaIO4 at 37° C. The adhesive here is 
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Figure 5.3 Elastic modulus of complex coacervates, made with varied methacrylations 
on 40 MOEP polymers and polyamine polymers, at pH 7.2, with 20mM NaIO4 at 37°C.
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Figure 5.4 Images of the geometry being lifted off the pelitier plate on the rheometer 
with complex coacervate adhesive in between: A) as the geometry is being pulled off, B) 
the adhesive stuck on both the top geometry and bottom pelitier plate in the back.
suggest that the coacervates we are using are not too stiff and have a potential to be used 
in this application. Compositions that are too stiff are left stuck on only one side, top 
geometry or the bottom plate.
The complex coacervate adhesive is crosslinked by sodium periodate as the 
chemical initiator. But the exact mechanism behind the crosslinking is unknown. Looking 
at the individual components of the adhesive one at a time on the rheometer, we taped 
into the mechanism (Figure 5.5). As shown in Figure 5.5A, 20% methacrylated 
polyphosphate polymer solution at a high concentration of 200 mg/mL (compared to 50 
mg/mL in the coacervate), with 20 mM NaIO4, at 37°C, show no crosslinking taking 
place. The nonmethacrylated polyamine polymer solution, without any initiator added at 
37°C, pH 9, also does not crosslink (Figure 5.5B). The nonmethacryalted polyamine at 
pH 9, with 20 mM NaIO4, at 37°C, however, does crosslink at very low modulus (Figure 
5.5C). When we monitor the effect of pH on plateau modulus on 5% methacrylated 
polyamine solution, we see the modulus increasing with increasing pH (Figure 5.5D). At 
pH 5 the 5% methacrylated polyamine solution does not crosslink, but with increasing pH 
after that the polyamine crosslinks. For periodate crosslinking to take place, all we need 
is the presence of sodium periodate and polyamine. Methacrylation on the polyamine 
gives a more profound effect. At pH 7.2 the nonmethacrylated polyamine does not show 
any crosslinking.
5.3.2 Mechanical Testing
The adhesion properties of the complex coacervate adhesive were tested via lap 
shear mechanical test on the Instron. The bonded aluminum adherends were cured and 
tested after 2 hours of submersion underwater, at 37°C. The lap shear measurements
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Figure 5.5 Sodium periodate mechanism: A) Elastic and viscous modulus of 70 MOEP- 
20% methacrylated polymer solution with 20 mM NaIO4, at pH 9 37° C. B) Elastic 
modulus of nonmethacrylated polyamine at pH 9, 37° C. C) Elastic and viscous modulus 
of nonmethacrylated polyamine at pH 9, with 20 mM NaIO4 37° C. D) Elastic modulus 
plateau of 5% methacrylated polyamine at varied pH’s, with 20 mM NaIO4, at 37°C.
were made on the complex coacervates of 40 MOEP, varied methacrylation polymers 
with 5% methacrylation on the polyamine, with PEG-dA entrapped within the coacervate 
network (Figure 5.6). The bonding results showed increased bond strength over 
increasing PEG-dA concentration, and increasing methacrylation on the polyphosphate 
polymer. The maximum mean bond strength was measured for the 40 MOEP -  15% 
methacrylated polyphosphate polymer within a coacervate containing 15 wt% PEG-dA 
concentration, of 473 ± 82 KPa. Each value is a measure of four bonded substrates. Bond 
strength of 70 MOEP -  20% methacrylated polyphosphate coacervate with 5% 
methacrylation was also tested as shown in Figure 5.7. The bond strength also increased 
with increasing amounts of PEG-dA concentration, reaching a maximum of 437 ± 118 
KPa.
5.3.3 Cytotoxicity
The direct contact cytotoxicity assay was used to measure the toxicity of the 
complex coacervate (Table 5.1). Mouse osteoblast cell line MC3T3-EI was used. The 
uncrosslinked coacervate made from 70 MOEP-20 % methacrylated polymer with 5% 
methacryalted polyamine was not toxic. All of the polymer syntheses were purified of 
toxins, and this result confirms it. The crosslinked coacervate was tested with 10mM 
NaIO4 concentration and was also not toxic. At high concentration, above 50 mM, 





Figure 5.6 Lap shear on aluminum substrates testing 40 MOEP coacervates with varied 
PEG-dA (575) concentration and varied methacrylation on polyphosphate polymer, 















Figure 5.7 Lap shear on aluminum substrates testing 70 MOEP, 20% methacrylation 
polyhphosphate coacervate with varied PEG-dA (575) concentration, bonded for 2 hours 
underwater at 37°C using 20 mM NaIO4.
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Table 5.1 Cytotoxicity by direct contact cell assay, using mouse osteoblast cell line, was 
measured on 70 MOEP-20 % methacrylated polymer with 5% methacryalted polyamine 
coacervate.
Samples % cell 
Survival
Toxicity
70 MOEP-20% Methacrylation CC, uncrosslinked 81.1% Not Toxic
70 MOEP-20% Methacrylation CC, 10 mM NaI04 84.3% Not Toxic
5.3.4 Sterile Adhesive Complex Coacervate Packets used in Pig 
Animal Surgeries
Sterile adhesive packets were sent for pig animal studies that took place in 
University of Texas Houston, Fetal Center (Figure 5.8). Pregnant Pigs were used as the 
animal model to test the twin-to-twin transfusion syndrome adhesive patch, as tested in 
vitro in Chapter 3. A normal pig is pregnant for 114 days, consisting of 5 to 8 fetal sacs. 
At day 70, (midterm), the fetal surgery is performed. Where in each animal some sacs 
were left alone as controls, some were tested with a Human Amniotic membrane (hAM 
plug only), and some were tested with underwater coacervate adhesive in conjunction 
with hAM (UAC + hAM).
Each sac, if tested for the hAM plug or hAM plug + UAC, was punctured and the 
patch was pulled through to plug the punctured fetal pig membrane as shown in Chapter
3, Figure 3.2. Pig is a good model for this study because the pregnant animal has many 
sacs. After the surgery, the animal is sent back to recovery. The animal is euthanized after 
21 days, and with histology study the fetal membrane specimens are examined.
Preliminary results of animal studies are showing positive results. The adhesive 
adheres well to the human aminiotic membrane (hAM) as well the defect site without any 
adverse effect to the fetus. It is a promising result, as well as a novel method to promote 
healing of human fetal defects after invasive fetal surgeries.
The stability of complex coacervate adhesives packets made for the pig animal 
study is tested over time for crosslinking kinetics as shown in Figure 5.9. The samples are 
made of coacervates of 70 MOEP-20% methacrylation on the polyphosphate polymer 
and 5% methacrylation on the polyamine polymer, 10 wt% PEG-dMA (Polyethylene
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Figure 5.8 Sterile complex coacervate adhesive packets used in the animal studies. One 
syringe contains the coacervate adhesive and the second the chemical initiator. Upon use, 
the two solutions are mixed by connecting the two syringes with a mixing nozzle. The 
adhesive/initiator are mixed by pushing out the matter from one syringe to the other, 
5-10 times, or 30 sec. The adhesive is then pushed into one syringe; the empty syringe is 
removed, with a cannula secured on the leur-lock adhesive syringe, and the adhesive is 
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Figure 5.9 Stability study of complex coacervate adhesive sent for pig animal studies, 
made of 70 MOEP-20% methacrylation on the polyphosphate polymer and 5% 
methacrylation on the polyamine polymer, 10 wt% PEG-dMA within the coacervate, pH 
7.2, with 35 mM NaIO4 concentrations at 37°C. Showing plateau elastic modulus of 
samples that are chemically cured adhesive over a time period.
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glycol dimethacrylate, MW 750) within the coacervate, pH 7.2, with 35 mM NaIO4 
concentrations at 37°C. PEG-dMA is a more stable monomer than the PEG-dA and was 
used for this animal study. The results show very stable coacervate packets. Even after 
110 days there is not much change in the elastic modulus.
5.4 Conclusion
Complex coacervate adhesive, inspired by the sandcastle worm, is unique because 
of its use in aqueous environments. The adhesive’s novelty lies in it being made in water, 
being applied under water, and adhering to wet surfaces. The synthetic adhesive 
properties were tuned to the design of the application. This adhesive was designed and 
developed for the TTTS, fetal membrane repair application. The adhesive adhered to pig 
fetal membrane tissue (with sufficient strength), cured in a controlled manner, is 
biocompatible, nontoxic, deliverable through an injectable system, and is stable for long 
term use. The methacrylated polymer complex coacervate was successfully chemically 
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CHAPTER 6
PHOTOPOLYMERIZED METHACRYLATED POLYMER 
COMPLEX COACERVATE ADHESIVE PATCH 
FOR SPINA BIFIDA
6.1 Introduction
There are 1,500 children born with Spina Bifida each year in the United States
[1]. Spina Bifida is a congenital birth defect with the neural tissue of the posterior spinal 
column of the fetus being exposed to the amniotic fluid. This condition is detected by 
ultrasound between 16 to 20 weeks of pregnancy. The exposed neural tissue, in the 
amniotic cavity, leads to many neurological impairments at birth like paraplegia, 
sphincter incontinence, cranial nerve disturbances, hydrocephalus, respiratory problems, 
and death in some cases [2-3]. The severity of Spina Bifida varies from case to case, with 
myelomeningocele (MMC) being the most severe, where the spinal column protrudes 
through an opening and a sac is formed enclosing the spinal material. Current treatment 
includes MMC repair surgery closing the neural defect. Animal studies have shown 
promising results if the repair of neural tube closure takes place in the life of a fetus 
[4-5]. MMC repair by fetal surgery poses major challenges and trauma for the patient 
[6]. In fetal surgery the repair takes place by closure of the fetal neural tube defects in a 
multilayer fashion by closing the final skin layers with sutures. This multilayering closure 
is lengthy in time and technically difficult to do [7]. To get maximum closure at times it
is necessary to add a secondary sutured patch [7-8]. Adding to the difficulty of the 
procedure, fetal membrane sac rupturing is another big risk. Animal studies are showing 
that instead of a major invasive fetal surgery, a minimally invasive fetal surgery covering 
the MMC defect with an adhesive patch until birth, followed by a more complex open 
surgery at birth, could be just as effective in better outcome of the life of the baby [9-10]. 
But the difficulty lies in the delivery of an adhesive patch under aqueous conditions in the 
amniotic sac to seal the spina bifida defect. Out of the bioadhesives available 
commercially, eventually all will fail under aqueous conditions over time.
Marine organisms living in watery interfaces have solved the challenges that we 
face in developing bioadhesives in aqueous conditions [11]. The sandcastle worm, also 
known as P-californica living along the coastline of California has a unique way of 
constructing composite mineralized shells that it lives in by binding sandgrains and shells 
from aquatic environments by small amounts of underwater adhesive that it secretes. 
Despite all the turbulent forces in the ocean, the shell that it lives in does not fall apart. 
We have copied the chemistries and mechanism of this worm glue to make a synthetic 
analog bioadhesive [11-14]. Chemistries that we have mimicked in the synthetic version 
are the oppositely charged proteins, phosphates and amines, and divalent cations that 
form an adhesive by the method of complex coacervation. Coacervation is defined as 
phase separation of solution mixture into one rich and one poor phase of particular 
components. Bungenberg de Jong in 1929 [15] named complex coacervates as phase 
separation of two oppositely charged polyelectrolytes, separating into a dense coacervate 
and dilute supernatant [16]. The oppositely charged water-soluble polymers, 
polyphosphate and polyamine, form the synthetic adhesive, by coacervation.
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Our current research is focused on developing a synthetic underwater adhesive 
targeted for medical applications, in particular soft tissue adhesion. These biomimetic 
adhesives are advantageous because they can build on the natural phenomena and yet 
have highly tunable physical and mechanical properties [17]. With an application in mind 
the biomimetic can be tailored to the needs of a commercial product. In the past we have 
targeted high strength injectable multiphase adhesive coacervate for biomedical 
applications and attained our goals of a high strength deliverable adhesive through a fine 
cannula [14]. In this chapter, our focus is to develop an adhesive for Spina Bifida. An 
ideal solution would be a fast and simple adhesive patch that can minimize the 
complication and time of this fetal procedure [18]. We want to make an adhesive patch 
that we can deliver and apply under amniotic fluid, by a minimally invasive fetal surgery. 
Photopolymerizing the complex coacervate adhesive patch with sufficient strength would 
solve the fast curing problem under water. The fetoscope already has a light source 
attached to it to view inside the dark amniotic sac, which can be used to insert the laser to 
photocure the adhesive. The advantage of photopolymerization is that it is fast, simple, 
controllable, and well established [19-21]. In the case of Spina Bifida, 
photopolymerization is a great technique for fast underwater curing, with minimally 
invasive procedure. In this study nontoxic water-soluble photoinitiators Eosin-Y with low 
concentrations of triethanolamine (TEA) were used [22]. The crosslinking kinetics and 
tailoring of the elastic modulus were monitored on the rheometer. The adhesion 
properties of the photocrosslinked adhesive were measured on a double lap shear test, on 
commercially available Strattice (Life Cell Corp.) and semitransparent skin graft material 
Dermafill (AMD-Ritmed), used as a patch. The cytotoxicity was evaluated. Sterile
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adhesive packages were created for sheep animal surgeries. Current sheep studies are 
using the sterile adhesive packets designed for the Spina Bifida adhesive patch.
6.2 Materials and Methods
6.2.1 Materials
All reagents were used without further purification unless noted otherwise. PEG- 
dA (Polyethylene glycol diacrylate, 540 Da) and basic aluminum oxide were purchased 
from sigma-aldrich. Eosin-Y was purchased from Acros Organics. Triethanolamine 
(TEA, >98.0%) was purchased from Alfa Aesar.
6.2.2 Purification of PEG Monomers
The inhibitor in PEG-dA monomer had to be removed. The liquid monomer was 
passed through an activated basic aluminum oxide column to remove the inhibitor, 
hydroquinone monomethyl ether (MEHQ).
6.2.3 Complex Coacervate Adhesive Formation
Methacrylated Poly(MOEP-co-MAA) (as described in Chapter 4) and 
methacrylated Poly(acrylamide-co-aminopropyl methacrylamide) (as described in 
Chapter 4), were dissolved separately, in aqueous 150mM NaCl solution, at a 
concentration of 50 mg/mL. The copolymer solutions were adjusted to the correct pH of 
7.2±0.2, with NaOH. The poly(acrylamide-co-aminopropyl methacrylamide) solution 
was added dropwise, to the poly(MOEP-co-MAA) solution, under vortex. The molar 
ratio of amine sidechains to phosphate sidechains (A/P) was fixed. For 40 MOEP 
polymer coacervate, an A/P ratio of 1 was used and for 70 MOEP polymer coacervate, an 
A/P ratio of 0.65 was used. In less than a minute, turbid coacervate settled out of solution.
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The coacervate was allowed to phase separate from the supernatant for 24 hrs before 
being used for further analysis. The multiphase complex coacervate incorporating PEG- 
dA was formed the same way with an additional step of dissolving the desired 
concentration (0-15 wt%) of PEG-dA into dissolved methacrylated Poly(MOEP-co- 
MAA) polymer, taking into account a fixed volume in the end.
6.2.4 Dynamic Rheology
Gelation kinetics of the coacervates were conducted on a stress-controlled 
Rheometer (TA instrument, AR 2000 ex) using a 20 mm 4° cone geometry, gap 114 ^m, 
at 25°C with 150 |iL coacervate samples. Crosslinking of the coacervates was measured 
using the Oscillatory time sweep method on the Rheometer. The change in elastic (G') 
and viscous (G'') moduli over time was measured at a constant frequency of 1 Hz and 
constant strain of 1%. The coacervates were crosslinked through vinyl groups on both 
polymers. The coacervates were photocrosslinked using 69 ^g/ml eosin-Y, and 40 mM 
TEA photoinitiators. The photocuring accessories were also purchased from the TA 
instruments. The 10 ^l stock solution of photoinitators was mixed into 200 ^l coacervate. 
The mixed coacervate was loaded onto the rheometer, and the method initiated. The 
samples were irradiated from below through a quartz plate for 10 s (320-500 nm, 750 
mW cm-2) using a liquid-filled light guide from Hg light source (Exfos S1000).
6.2.5 Mechanical Testing
The adhesion properties of complex coacervates were tested using a lap shear test 
on a material testing system (Instron), cured by photopolymerization. Commerically 
available porcine tissue Strattice (Life Cell Corp.) and a semitransparent skin graft
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Dermafill (AMD-Ritmed) were used as substrates. The strattice and dermafill were cut 
into 2 cm x 1 cm strips, where the strattice was soaked in 150 mM NaCl salt solution and 
the dermafill left dry. The prepared coacervates were mixed with Eosin-Y and TEA. Two 
pieces of strattice were put next to each other, so the combined length is 4 cm. To each 
strip, 20 ^l of coacervate was applied to 1 cm of each strip right next to each other, and a 
dry dermafill sample was placed on the two strips with the final overlay area holding the 
strips together be 2 cm x 1 cm. A dermafill was pressed down with a gloved finger to 
even out the adhesive before photocuring. The adhesive was allowed to soak into the 
dermafill for 1 min, while still keeping the strattice soaked within a tissue of 150 mM 
NaCl to prevent dehydration of the tissue. The overlapped area was photocured by 
irradiating each cm2 from 5 mm above the sample using a liquid-filled light guide from 
Hg light source for 20 s (320-500 nm, 750 mW cm-2). The photocrosslinked strattice- 
dermafill-strattice samples were then put into a moisture chamber to prevent dehydration 
for 20 min after curing. The samples were tested on the Instron, 100 N load cell, 
crosshead speed 10 mm min-1. The substrates failed at one of the two strattice-dermafill 
overlaps, and that failed load was taken into account along with the overlap area to 
calculate the shear strength. For each condition, four specimen/measurements were made 
and tested.
6.2.6 Swelling Measurements
Photopolymerized complex coacervate gels were tested for swelling in 150 mM 
NaCl. Varied PEG-dA concentration coacervates were prepared and mixed in with the 
photoinitator (Eosin-Y and TEA). Each sample was photocured, with 750 mW cm-2 
irradiance, 20 s, in a 7.72 mm disk shaped molds. After photocuring, the samples were
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allowed to fully set for 20 min in a moisture chamber to prevent dehydration of the gels. 
Once solidified, the gels were removed from the mold and immersed in 150 mM NaCl 
solution in a closed chamber. The swelling dimension measurements were made from the 
images taken from time zero to various time points over a period of 1 month. Time zero 
point was measured after immersing the gel in solution after 30 s. Varied PEG-dA 
concentration gels were measured for two different temperatures (RT, and 37°C) and 
various time points (0, 4 h, 12 h, 24 h, 2 d, 3 d, 7 d, 14 d, 21 d, 28 d). An average of three 
measurements were taken at each set of data points.
6.2.7 Cytotoxicity1
Mouse osteoblasts (MC3T3-E1 subclone 4, ATCC CRL-2593, Manassas, VA, 
USA) were used as the cell line. The cells were maintained in essential medium 
supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 ^g/ml 
streptomycine in a humidified 5% CO2 and 95% air balanced incubator at 37oC. The 
medium was changed every other day. The direct contact cell culture test was used to 
evaluate cytotoxicity of the complex coacervate. To 32 pil, adhesive uncrosslinked or 
crosslinked, and 256 ^l medium was added into a culture well plate and incubated at 
37°C for 24 hours. In another plate MC3T3-E1 osteoblast cells were plated, with density 
of 100, 000 cells/well in the growth medium, incubated at 37°C for 48 hours. After 48 
hours the medium from the MC3T3-E1 cells was removed, and from the adhesive plate 
the medium was added into the cell plate. After 48 hours the cell number of MC3T3 on 
the adhesive was determined using the MTT assay. MTT was dissolved in sterile PBS (5 
mg/ml). 100 pd of the MTT stock solution was added to each well and incubated at 37oC
1Hui Shao carried out the cytotoxicity assay.
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for 4 hours. After incubation, 1000 ^l of the SDS-HCl solution (0.1 g/ml in 0.01 M HCl) 
was added to each well and mixed thoroughly using pipette to extract the formazan 
crystals. The plate was then incubated at 37oC for another 4 hours in a humidified 
chamber. After incubation, the extract of each sample was transferred to 96-well plate, 
and the absorbance intensities were measured at 570 nm using a microplate reader.
6.2.8 Sterilization of Coacervates
Sterile coacervate adhesive packets were prepared for the animal studies. In a 
sterile hood, all aqueous polymeric solutions were filtered through a 0.22 ^m sterile 
filter. The sterile poly(acrylamide-co-aminopropyl methacrylamide) solution was added 
dropwise to the sterile poly(MOEP-co-MAA) solution under vortex. The coacervates 
were ripened for 24 hours. The adhesives were packed in 1 mL syringes with a tight seal 
cap (Qosina, Inc), sterilized by ethylene oxide sterilization (40°C). The loaded sterile 
syringe was then put into a sterile 50 mL centrifuge tube to be kept in a sterile packet till 
surgery. The PEG-dA, TEA, and Eosin-Y stock solutions were filtered through the a 0.22 
^m filter to make it sterile. The photoinitators and PEG-dA were loaded into the second 
syringe the same way.
6.2.9 Complex Coacervate Adhesive Packets Used in Animal Studies
The adhesive and the initiator were packaged separately in two different leur-lock 
sterile syringes. At the animal study surgery room, a sterile mixing nozzle was connected 
to the two syringes by pushing all of the material of one syringe into the other, and vice 
versa, 5-10 times mixed in the initiator with the adhesive. Once mixed, all of the 
adhesive/initiators were pushed into one syringe, the empty syringe was removed, the
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mixing nozzle was removed, and the cannula was attached to the leur-lock syringe 
adhesive and applied to the test site. The adhesive was applied within a few minutes of 
mixing and was photocured using a laser (Iridex, green laser 532 nm).
6.3 Results and Discussion
6.3.1 Oscillatory Rheology
Complex coaceravates of varied polyphosphates and polyamines (as shown in 
Chapter 5, Figure 5.1) were photopolymerized on the rheometer. In photopolymerization, 
the photoinitiators were dissociated with the use of light into free radicals, which react 
with functionalized macromers, with double or triple bonds, to propagate radical chain 
polymerization [23]. In this study we used photoinitiators outside the UV range, in the 
visible light range, to maintain the integrity of the fetal tissue. Eosin-Y (absorbance peak 
of 510 nm) and TEA were used as the photoinitiators to photocure the complex 
coacervate adhesive. Visible light source connected to the rheometer using a light guide 
was used to cure the glue for all rheology measurements. The crosslinking kinetics of the 
complex coacervates were evaluated on the rheometer by first optimizing the 
photoinitiators. Eosin-Y, commonly used water-soluble nontoxic photoinitiator, 69 ^g/ml 
[24] were used throughout this study. The TEA concentration was optimized by the 
oscillatory rheology, time sweep, method as shown in Figure 6.1. Complex coacervates 
made of 40 MOEP -  4% methacrylation on the polyphosphate and 5% methacrylation on 
the polyamine polymer with 5 wt% PEG-dA within the coacervate, at pH 7.2 were 
crosslinked with fixed Eosin-Y and varied amount of TEA. Crosslinking took place in 10 
seconds, with maximum modulus reaching 106 KPa at 40 mM TEA concentration. As 
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Figure 6.1 Optimizing TEA concentration vs. Elastic modulus plateau: photpolymerized 
complex coacervate made of 40 MOEP -  4% methacrylation on the polyphosphate 
polymer and 5% methacrylation on the polyamine polymer, 5 wt% PEG-dA, pH 7.2, 
photocrosslinked with 69[j,g/mL Eosin-Y, and varied TEA, at 750 mW/cm2 irradiance for 
10 sec. With an increasing amount of TEA added to the coacervate, the pH of the 
coacervate changed.
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7.2 to an increased amount as shown in Figure 6.1. The increased pH effect of the 
coacervate would disrupt the coacervate phase and not be good. The maximum TEA 
concentration of 40 mM, however, did not change the pH of the coacervate phase. The 
effect of the second phase, PEG-dA, on the coacervate was also analyzed in rheology 
(Figure 6.2). The 40 MOEP-1% methacrylation polymer coacervate was evaluated for 
increasing PEG-dA concentration after photocrosslinking. As the PEG-dA concentration 
(wt%) increased, the plateau elastic modulus also increased tremendously for even 1% 
methacrylated polyphosphate within the coacervate. Within 10 seconds, we get a stiff 
coacervate network with increasing PEG-dA. The effect of methacrylation on modulus 
was difficult to measure for higher methacrylated polymers due to delamination of the 
samples and slippage from the geometry.
6.3.2 Mechanical Testing
The adhesion properties of the complex coacervate adhesive were tested via a lap 
shear test on the Instron. Commercially available soft tissue material Strattice, 
decellularized porcine dermis tissue, was used. Strattice is a uniform material that gave us 
consistent comparable bond strength data. To patch the adhesive for a photopolymerized 
adhesive patch Dermafil, translucent bacterial cellulose wound dressing material was 
used. The transparent dermafil allowed penetration of light through the patch for 
photopolymerization to occur. The strattice-dermafil substrates were bonded in a double 
lap shear method as shown in the drawing in Figure 6.3A (left). The adherends failed 
from one of the two overlaps, and the load at failure and the area at failure was taken into 
account to get a bond strength value. The tissue substrates stretched slightly before 








Figure 6.2 Elastic modulus of complex coacervate made of 40 MOEP -  1% 
methacrylation on the polyphosphate polymer and 5% methacrylation on the polyamine 
polymer, with varied PEG-dA (wt% concentrations), pH 7.2, photocrosslinked with 






































Figure 6.3 Double lap shear tissue adhesion test with stratus-dermafill-stratus: A) 
Drawing of the substrates under tension (left), with the image of the sample under 
loading (right). B) Bond strength data of 40 MOEP -  varied methacrylation polymer and 
5% methacrylated polyamine coacervates, with varied PEG-DA concentrations within the 
coacervate phase, pH 7.2. Photocrosslinked with 69(j,g/mL Eosin-Y, and 40 mM TEA, at 
750 mW/cm irradiance for 20 sec, under wet conditions, and tested after 20 min on the 
Instron.
bonding measurements with stratus-dermafill-stratus substrates is shown in Figure 6.3B. 
The bond strength data of 40 MOEP polymer with varied methacrylation and 5% 
methacrylation on the polyamine, with varied PEG-dA concentration coacervates at pH 7.2 
were made. The samples were photocrosslinked with 20 sec exposure per cm2 at irradiance 
of 750 mW/cm2. The bonding results show an increase in bond strength over increasing 
PEG-dA concentration and increasing methacrylation on the polyphosphates, within the 
coacervates. The maximum bond strength was reached for 40 MOEP-15% methacrylated 
polyphosphate polymer with 15 wt% PEG-dA at 92 ± 30 KPa. The bond strength increase 
with increasing PEG-dA concentrations could be a result of the second polymer network 
within the coacervate network (Figure 6.4). Where the mechanical properties of the double 
network are much stronger than each individual component.
6.3.3 Swelling of Complex Coacervate Gels
The swelling behavior of the crosslinked complex coacervate adhesive is essential 
to the analysis of our adhesives. Whenever something is injected into the body, we do not 
want the material to swell in an uncontrolled manner. In terms of adhesives you do not 
want the adhesive to swell or shrink in an uncontrolled manner and form a interface 
mismatch. The swelling behavior of the photocrosslinked complex coacervate disks was 
evaluated and immersed in 150 mM NaCl solutions at two different temperatures (RT 
and 37°C) as shown in Figure 6.5. The disks hardly swelled over a month period for both 
coacervate gels made with 0 wt% PEG-dA and 15 wt% PEG-dA within the coacervates. 
Disk dimension measurements were made for coacervate gels with varied PEG-dA 
concentrations at two different temperatures (RT and 37°C), as shown in Table 6.1. The 
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Figure 6.4 Multiphase complex coacervate PEG-dA network created by 
photocrosslinking.
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Figure 6.5 Images comparing the swelling behavior of photopolymerized disks at time 
zero to 28 days, made of 70 MOEP -  20% methacrylation polymer and 5% methacrylated 
polyamine coacervates, with 0 and 15 wt% PEG-DA concentrations within the coacervate 
phase, at pH 7.2, photocrosslinked with 69p,g/mL Eosin-Y, and 40 mM TEA, at 750 
mW/cm2 irradiance for 20 sec, under wet conditions.
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Table 6.1 Swelling measurements over time: disk diameters are compared for swelling 
for samples made of 70 MOEP -  20% methacrylation polymer and 5% methacrylated 
polyamine, with 0, 5, 10, and 15 wt% PEG-DA concentrations within the coacervate 
phase, at pH 7.2. Coacervates were photocrosslinked with 69^g/mL Eosin-Y, and 40 mM 
TEA, at 750 mW/cm2 irradiance for 20 sec, under wet conditions.
Swelling Disk Dimensions (cm) at 25° C over time
Time 0 PEG-dA 5 PEG-dA 10 PEG-dA 15 PEG-dA
(Days) CC CC CC CC
0 0.70±0.00 0.72±0.01 0.70±0.00 0.70±0.00
0.25 0.69±0.02 0.72±0.01 0.70±0.00 0.70±0.01
1 0.70±0.01 0.72±0.01 0.70±0.01 0.70±0.01
2 0.70±0.01 0.72±0.02 0.70±0.00 0.70±0.00
5 0.69±0.01 0.73±0.01 0.71±0.02 0.70±0.00
7 0.69±0.01 0.72±0.00 0.70±0.00 0.69±0.01
14 0.69±0.01 0.73±0.01 0.70±0.01 0.70±0.00
28 0.71±0.02 0.71±0.01 0.70±0.01 0.70±0.01
Swelling Disk Dimensions (cm) at 37° C over time
Time 0 PEG-dA 5 PEG-dA 10 PEG-dA 15 PEG-dA
(Days) CC CC CC CC
0 0.71±0.01 0.73±0.02 0.70±0.01 0.70±0.00
0.25 0.71±0.02 0.73±0.02 0.70±0.01 0.70±0.01
1 0.70±0.01 0.73±0.01 0.70±0.00 0.70±0.00
2 0.70±0.01 0.73±0.01 0.70±0.00 0.70±0.00
5 0.71±0.01 0.72±0.01 0.70±0.01 0.70±0.00
7 0.69±0.00 0.72±0.01 0.70±0.00 0.70±0.01
14 0.71±0.02 0.73±0.01 0.71±0.01 0.70±0.00
28 0.70±0.01 0.73±0.02 0.70±0.00 0.70±0.00
month, showing dimensional stability of our crosslinked coacervates.
6.3.4 Cytotoxicity
The direct contact cytotoxicity assay was used to measure the toxicity of the 
photocrosslinked complex coacervate adhesive (Table 6.2). The methacrylated polymer 
coacervate photocrosslinked and had cell survival of 93.8%, showing minimal toxicity. 
Special care was used to make sure no toxins are picked up during the synthesis of all 
reagents and polymers to eliminate any contaminants.
6.3.5 Sterile Adhesive Complex Coacervate Packets used in Pig 
Animal Surgeries
Animal studies took place at the University of Texas Houston, Fetal Center. 
Pregnant sheep with twins were the chosen animal model to test the spina bifida adhesive 
patch. A normal sheep is pregnant for 147 days. To mimic the conditions of the spina 
bifida, a neural defect was created on the sheep fetuses on day 75. The sheep were closed 
up, and repair of that defect took place on day 95 with the adhesive patch. The sterile 
adhesive packets were used (Chapter 5) with the transparent dermafil patch to repair the 
neural defect. On day 135 the sheep delivered, and the animals were euthanized. The fetal 
membrane specimens were examined. Preliminary studies with sterile adhesive packets 
are being conducted at the fetal center, and are showing promising results. Making this 
adhesive patch work under amniotic fluid through a fetoscope is a major challenge. It will 
take many trials and errors to make this work.
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Table 6.2 Cytotoxicity by direct contact cell assay, using mouse osteoblast cell line, was 
measured on 70 MOEP-20 % methacrylated polymer with 5% methacryalted polyamine 
coacervate.
Samples % cell 
Survival
Toxicity
Medium only, 750 mW/cm2 for 20 sec light exposure 91.8% Not Toxic
Methacrylated Polymer CC, uncrosslinked 83.3% Not Toxic
Methacrylated Polymer CC, Photocrosslinked 93.8% Not Toxic
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6.4 Conclusion
Biomimetics are unique because they are built on nature’s concept to design a 
synthetic with tunable properties, for interest to a particular application. A 
photopolymerizable complex coacervate adhesive patch was developed for MMC repair. 
Photopolymerization is fast and easy and gives access to difficult spatial positions. Our 
complex coacervate adhesive is easily deliverable through a fine cannula and can be 
laser-cured in the amniotic sac. We are able to tune the elastic modulus by changing the 
PEG-dA concentration and % methacrylation within the coacervates. High bond 
strengthfor underwater adhesion was achieved by incorporating higher methacrylation 
and higher PEG-dA content. These coacervate adhesives did not swell, which is 
advantageous to the injectable system. The adhesive is not toxic and is being used in 
sheep animal studies using sterile adhesive packets. The preliminary results show 
promising results in adhering the adhesive patch to fetal tissue.
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CHAPTER 7
CONCLUSION
An adhesive for sealing fetal defects, in utero, was developed by the method of 
complex coacervation. Soft tissue adhesives, and adhesives in general, are limited and 
pose a major challenge under wet environments. A water-borne synthetic complex 
coacervate adhesive, inspired by the Sandcastle worm, was developed by mimicking the 
basic protein chemistries of the worm for sealing fetal defects in aqueous conditions.
The synthetic analog of the sandcastle worm adhesive consisted of oppositely 
charged phosphate and amine copolyelectrolytes that when mixed under the right 
conditions formed a complex coacervate adhesive in aqueous solution at the biological 
pH. The liquid-liquid phase separation resulted in a dense (coacervate) and a dilute 
(supernatant) phase. The liquid coacervate phase can be applied underwater to various 
surfaces, where it stays in place, does not disperse, and is water-immiscible. The 
viscosity of the coacervate can be tailored to the desired application by adjusting the A/P 
ratio.
The complex coacervate adhesive is cured through the methacrylated sidechains 
on both copolyelectrolytes, polyphosphates and polyamines. The polyphosphate, 
Poly(MOEP-co-MAA) polymer, was methacrylated by glycidyl methacrylate (GMA) and 
grafted under aqueous conditions to keep the toxic solvents out. The polyamine, Poly 
(acrylamide-co-aminopropyl methacrylamide) was synthesized using aqueous RAFT
polymerization with methacrylated sidechain resulting from addition of MAA and EDC. 
The targeted methacrylation on each copolyelectrolyte resulted in tunable mechanical 
properties of the adhesive.
Multiphase complex coacervate adhesive resulted from the incorporation of a 
water-soluble PEG-dA monomer entrapped within the coacervation phase. Coacervate 
acted as a container for a water-soluble molecule, which could be accurately delivered to 
the site without losing its cargo. Upon simultaneous crosslinking of the coacervate 
network and PEG-dA network resulted in substantial improvement in the bond strength 
of the bioadhesive. The PEG-dA also made the coacervates more viscous. Despite the 
high viscosity, these complex coacervate adhesives could easily be ejected through a fine 
gauge cannula. This was due to the shear thinning behavior of this complex coacervates. 
This allowed highly viscous adhesives to be delivered at difficult to reach sites, making 
this adhesive very useful for minimally invasive procedures.
Fetal defect repair, due to iatrogenic preterm premature rupture of the fetal 
membrane, could greatly benefit from a good underwater adhesive to seal the ruptured 
membranes. An in vitro model using the complex coacervate adhesive in conjunction 
with a lyophilized fetal membrane patch showed an effective way to plug the iatrogenic 
fetal membrane defect under aqueous conditions. The toxicity of the adhesive in direct 
contact with human fetal membrane in organ culture setting showed no toxicity. These 
preliminary results were important to taking this adhesive to the next step, the animal 
studies.
A chemically crosslinked complex coacervate adhesive of the methacrylated 
polymers was developed for sealing fetal membrane rupture after a fetoscopic procedure
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in twin-to-twin transfusion syndrome treatment. The coacervate was crosslinked using 
sodium (meta) periodate crosslinker, reaching gelation point within a minute after adding 
the crosslinker, and fully curing into a hard gel in less than 10 minutes. The elastic 
modulus of the adhesive was tailored to modulus of the fetal tissue by controlling the 
methacrylated groups within the coacervate. The adhesive had sufficient strength, and 
increased with increasing amounts of PEG-dA concentration and methacrylation within 
the coacervate. Direct contact cell culture of MC3T3-EI, in vitro, showed no toxicity of 
the methacrylated polymer complex coacervate. Sterile coacervate adhesive packets were 
developed to use in animal studies. Animal surgeries are showing promising results of the 
adhesive with the amniotic membrane patch to plug the fetal membranes after a 
fetoscopic defect. The adhesive adheres well to the plug patch as well as the pig fetal 
membranes. No toxicity in the animal after histological studies were seen.
A photocrosslinked complex coacervate adhesive patch was developed for sealing 
the neural spine defect in Spina Bifida. The adhesive patch is designed to cover the 
exposed neural tissue of the fetus under the amniotic sac through a minimally invasive 
fetoscope, where the adhesive is applied under amniotic fluid and photocured using a 
green laser diode. Photopolymerization of the complex coacervate crosslinking the 
adhesive through the vinyl bond of the methacrylation groups of polyelectrolytes is fast 
and easy and allows access of the adhesive through fine cannula to a difficult spatial 
position to be photocured in a controlled manner. Nontoxic visible light photoinitiators, 
Eosin-Y and TEA, were used. Elastic modulus of the coacervate was tuned by controlling 
the PEG-dA content within the coacervate. Bond strength on commercially available 
decellularized porcine dermis tissue (Strattice) and a translucent bacterial cellulose patch
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(Dermafil) was measured on a double lap shear test. Increasing the PEG-dA content and 
methacrylation on the polymers within the coacervate achieved high bond strengths. The 
swelling measurements concluded dimensionally stable complex coacervate at biological 
conditions of pH, salt solution, and temperature. The photopolymerized coacervates were 
not toxic and were further taken to sheep animal studies. Sterile adhesive packets are 
being used in the animal studies. Preliminary results from the sheep studies are showing 
promising results.
The developed injectable complex coacervate adhesives adhere well to the fetal 
tissue, in utero. The complex coacervates used are very stable, up to months, when 
packaged in the sterile syringes. For the application of TTTS and Spina Bifida this is a 
huge milestone. Taking research from a concept based on the inspiration of the 
underwater adhesive of the sandcastle worm to a practical application in animal studies is 
a huge step forward. Currently there is no glue in the market that can seal fetal membrane 
tissue under aqueous condition with sufficient bond strength while maintaining the 
integrity of the fetal tissue.
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